will filter after docket loads

Ravgen, Inc. v. Biora Therapeutics, Inc.

1:20-cv-01734 | Delaware District Court

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Division Wilmington
Judge Judge Jennifer L. Hall
Filed Dec. 21, 2020
Terminated Sept. 9, 2024
Case Flags CLOSED, MOTREF, and PATENT
Nature of Suit 830 Patent
Cause 35:1 Patent Infringement
Jury Demand Plaintiff
Patents 7,332,277 and 7,727,720
Last Updated: 8 hours ago Show Interactive Timeline
Filing Date # Docket Text
10/26/2024Official Transcript of held on 8-14-24 before Judge Hall. Court Reporter Stacy Ingram,Email: stacy_ingram@ded.uscourts.gov. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 11/18/2024. Redacted Transcript Deadline set for 11/26/2024. Release of Transcript Restriction set for 1/24/2025. (Ingram, Stacy) (Entered: 10/26/2024)
9/11/2024REDACTED VERSION of (423 in 1:20-cv-01734-JLH, 540 in 1:20-cv-01646-JLH) Unopposed MOTION to Redact (534 in 1:20-cv-01646-JLH) Transcript,, by Ravgen, Inc.. (Attachments: # 1 Exhibits A-B, # 2 Text of Proposed Order)(Farnan, Brian) (Entered: 09/11/2024)
9/9/2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,727,720 B2; US 7,332,277 B2. (Attachments: # 1 Stipulation of Dismissal)(ceg) (Entered: 09/09/2024)
9/9/2024
  • Motion to Dismiss (Demurrer)
SO ORDERED, re 424 Stipulation of Dismissal. (***Civil Case Terminated). Signed by Judge Jennifer L. Hall on 9/9/2024. (ceg) (Entered: 09/09/2024)
9/9/2024
  • OrderGranted
ORDER granting (423 in 1:20-cv-01734-JLH, 540 in 1:20-cv-01646-JLH) Unopposed Motion to Redact Transcript (D.I. 534 in 20-cv-1646-JLH). Signed by Judge Jennifer L. Hall on 9/9/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 09/09/2024)
9/4/2024
  • Motion to Dismiss (Demurrer)
STIPULATION of Dismissal by Ravgen, Inc.. (Farnan, Brian) (Entered: 09/04/2024)
9/4/2024
  • Motion to Redact
[SEALED] Unopposed MOTION to Redact (534 in 1:20-cv-01646-JLH) Transcript,, - filed by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Text of Proposed Order)(Farnan, Brian) (Entered: 09/04/2024)
9/4/2024422
  • Order
ORAL ORDER: IT IS HEREBY ORDERED that the parties shall file a joint status report on or before September 4, 2024, unless a notice of dismissal is filed before then. Ordered by Judge Jennifer L. Hall on 9/4/2024. (ceg) (Entered: 09/04/2024)
9/3/2024NOTICE requesting Clerk to remove Alix Pisani as co-counsel.. (Silver, Daniel) (Entered: 09/03/2024)
8/29/2024Joint STATUS REPORT by Ravgen, Inc.. (Farnan, Brian) (Entered: 08/29/2024)
8/28/2024NOTICE of Intent to Request Redaction by Brian E. Farnan re (534 in 1:20-cv-01646-JLH) Transcript,, (Farnan, Brian) (Entered: 08/28/2024)
8/22/2024
  • Motion to Stay
SO ORDERED, re 417 Stipulation and Order to Stay Case until August 29, 2024. (*Case stayed). Signed by Judge Jennifer L. Hall on 8/22/2024. (ceg) (Entered: 08/22/2024)
8/22/2024
  • Motion to Stay
STIPULATION to Stay Case by Ravgen, Inc.. (Farnan, Brian) (Entered: 08/22/2024)
8/14/2024Minute Entry for proceedings held before Judge Jennifer L. Hall - Motion Hearing held on 8/14/2024 re Dispositive and Daubert Motions. (*Court Reporter Stacy Ingram.) Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 08/14/2024)
8/12/2024
  • OrderGranted
ORDER granting (414 in 1:20-cv-01734-JLH, 529 in 1:20-cv-01646-JLH) Defendants' Unopposed Motion for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices for purposes of the August 14, 2024 hearing. Signed by Judge Jennifer L. Hall on 8/12/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 08/12/2024)
8/12/2024
  • OrderGranted
ORDER granting (528 in 1:20-cv-01646-JLH, 413 in 1:20-cv-01734-JLH) Plaintiff's Motion for Limited Exemption from the Standing Order Regarding Personal Electronic Devices for purposes of the August 14, 2024 hearing. Signed by Judge Jennifer L. Hall on 8/12/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 08/12/2024)
8/12/2024CORRECTING ENTRY: The pdf for the proposed order found at D.I. 413 -1 has been replaced with a corrected version per the conversation with the filer and chambers. (ceg) (Entered: 08/12/2024)
8/9/2024
  • Motionby Δ
Unopposed MOTION for Exemption of Persons from the District of Delaware's May 17, 2024 Standing Order on Personal Devices - filed by Biora Therapeutics, Inc.. (Attachments: # 1 Proposed Order)(Joyce, Alexandra) (Entered: 08/09/2024)
8/9/2024
  • Motion
MOTION for Limited Exemption from the Standing Order Regarding Personal Electronic Devices - filed by Ravgen, Inc.. (Attachments: # 1 Text of Proposed Order)(Farnan, Brian) (Attachment 1 replaced on 8/12/2024) (ceg). (Entered: 08/09/2024)
8/9/2024412
  • Order
ORAL ORDER: IT IS HEREBY ORDERED that the Court is setting aside 2.5 hours for the hearing on the pending dispositive and Daubert motions scheduled for August 14, 2024 at 10:00 AM to be split evenly between the two sides. Ordered by Judge Jennifer L. Hall on 8/9/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 08/09/2024)
8/5/2024411
  • Order
ORAL ORDER: The Court will address the parties' dispute about the pretrial order (No. 20-1646, D.I. 525; No. 20-1734, D.I. 410) at the hearing on August 14, 2024. Ordered by Judge Jennifer L. Hall on 8/5/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 08/05/2024)
7/29/2024 Letter to The Honorable Jennifer L. Hall from Alexandra M. Joyce regarding Request for Guidance on Pretrial Order submissions. (Joyce, Alexandra) (Entered: 07/29/2024)
7/10/2024 Letter to The Honorable Jennifer L. Hall from Alexandra M. Joyce regarding Joint Proposal Concerning August 14, 2024 Hearing on Case Dispositive and Daubert motions. (Joyce, Alexandra) (Entered: 07/10/2024)
6/27/2024REDACTED VERSION of (477 in 1:20-cv-01646-JLH) Declaration, (372 in 1:20-cv-01734-JLH) Declaration by Ravgen, Inc.. (Attachments: # 1 Exhibit 1)(Farnan, Brian) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of (476 in 1:20-cv-01646-JLH) Declaration, (371 in 1:20-cv-01734-JLH) Declaration by Ravgen, Inc.. (Attachments: # 1 Exhibits AH-AI)(Farnan, Brian) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of (370 in 1:20-cv-01734-JLH) Statement, (475 in 1:20-cv-01646-JLH) Statement, by Ravgen, Inc.. (Farnan, Brian) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of (369 in 1:20-cv-01734-JLH) Reply Brief, (474 in 1:20-cv-01646-JLH) Reply Brief by Ravgen, Inc.. (Farnan, Brian) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of (467 in 1:20-cv-01646-JLH) Reply Brief, (368 in 1:20-cv-01734-JLH) Reply Brief by Ravgen, Inc.. (Farnan, Brian) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of 367 Declaration, by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits W-Z)(Joyce, Alexandra) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of 366 Reply Brief, by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of 365 Declaration, by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits A-V)(Joyce, Alexandra) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of 364 Statement, by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of 363 Statement, by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of 362 Statement, by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of 361 Statement, by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 06/27/2024)
6/27/2024REDACTED VERSION of 360 Reply Brief,, by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 06/27/2024)
6/24/2024REDACTED VERSION of (443 in 1:20-cv-01646-JLH, 343 in 1:20-cv-01734-JLH) Declaration, by Ravgen, Inc.. (Attachments: # 1 Exhibits 1-5)(Farnan, Michael) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of 355 Statement, by Ravgen, Inc.. (Farnan, Michael) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of 354 Statement, by Ravgen, Inc.. (Farnan, Michael) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of (453 in 1:20-cv-01646-JLH, 353 in 1:20-cv-01734-JLH) Statement by Ravgen, Inc.. (Farnan, Michael) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of (352 in 1:20-cv-01734-JLH, 451 in 1:20-cv-01646-JLH) Statement, by Ravgen, Inc.. (Farnan, Michael) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of (448 in 1:20-cv-01646-JLH, 350 in 1:20-cv-01734-JLH) Statement, by Ravgen, Inc.. (Farnan, Michael) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of (445 in 1:20-cv-01646-JLH, 346 in 1:20-cv-01734-JLH) Statement, by Ravgen, Inc.. (Farnan, Michael) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of (341 in 1:20-cv-01734-JLH, 441 in 1:20-cv-01646-JLH) Declaration,,,, by Ravgen, Inc.. (Attachments: # 1 Exhibits 1-25, # 2 Exhibits 26-47)(Farnan, Michael) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of (440 in 1:20-cv-01646-JLH) Answering Brief in Opposition,,, (339 in 1:20-cv-01734-JLH) Answering Brief in Opposition,,, by Ravgen, Inc.. (Farnan, Michael) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of (435 in 1:20-cv-01646-JLH, 338 in 1:20-cv-01734-JLH) Declaration, by Ravgen, Inc.. (Attachments: # 1 Exhibits 1-13)(Farnan, Michael) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of (337 in 1:20-cv-01734-JLH) Answering Brief in Opposition, (434 in 1:20-cv-01646-JLH) Answering Brief in Opposition, by Ravgen, Inc.. (Farnan, Michael) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of 351 Declaration by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-29, # 2 Exhibits 30-39)(Silver, Daniel) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of 349 Statement by Biora Therapeutics, Inc.. (Silver, Daniel) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of 347 Statement, by Biora Therapeutics, Inc.. (Silver, Daniel) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of 345 Answering Brief in Opposition, by Biora Therapeutics, Inc.. (Silver, Daniel) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of 344 Declaration by Biora Therapeutics, Inc.. (Silver, Daniel) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of 342 Statement, by Biora Therapeutics, Inc.. (Silver, Daniel) (Entered: 06/24/2024)
6/24/2024REDACTED VERSION of 340 Answering Brief in Opposition, by Biora Therapeutics, Inc.. (Silver, Daniel) (Entered: 06/24/2024)
6/20/2024
  • Order
SO ORDERED, re (376 in 1:20-cv-01734-JLH, 480 in 1:20-cv-01646-JLH) Stipulation and Order to Extend Time to submit public versions of the parties' May 30, 2024 filings to June 24, 2024. Signed by Judge Jennifer L. Hall on 6/20/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 06/20/2024)
6/20/2024 STIPULATION TO EXTEND TIME to file public redacted versions of the parties May 30 filings to June 24, 2024 - filed by Biora Therapeutics, Inc.. (Silver, Daniel) (Entered: 06/20/2024)
6/17/2024
  • Order
SO ORDERED, re (374 in 1:20-cv-01734-JLH, 478 in 1:20-cv-01646-JLH) Stipulation and Order to Extend Time to submit public versions of the parties' June 13, 2024 filings to June 27, 2024. Signed by Judge Jennifer L. Hall on 6/17/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 06/17/2024)
6/17/2024 STIPULATION TO EXTEND TIME to file public redacted versions of the parties' June 13 filings to June 27, 2024 - filed by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 06/17/2024)
6/14/2024NOTICE requesting Clerk to remove Nicholas Halkowski and Sarah Walker (Siedlak) as co-counsel.. (Joyce, Alexandra) (Entered: 06/14/2024)
6/13/2024[SEALED] DECLARATION re 369 Reply Brief Declaration of Garth D. Ehrlich by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Piergiovanni, Rosemary) (Entered: 06/13/2024)
6/13/2024[SEALED] DECLARATION re 369 Reply Brief Continued Declaration of Ben Nichols by Ravgen, Inc.. (Attachments: # 1 Exhibit AH, # 2 Exhibit AI)(Piergiovanni, Rosemary) (Entered: 06/13/2024)
6/13/2024[SEALED] STATEMENT re 349 Statement by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Piergiovanni, Rosemary) (Entered: 06/13/2024)
6/13/2024
  • Motion for Summary Judgment
[SEALED] REPLY BRIEF re 291 MOTION for Summary Judgment of No Inequitable Conduct and No Unclean Hands filed by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Piergiovanni, Rosemary) (Entered: 06/13/2024)
6/13/2024
  • Motion for Summary Judgment
[SEALED] REPLY BRIEF re 277 MOTION for Summary Judgment of No License and No Release filed by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Piergiovanni, Rosemary) (Entered: 06/13/2024)
6/13/2024[SEALED] DECLARATION re 366 Reply Brief, Declaration of Harry Hanson in Support of Reply Brief in Support of Defendants' Daubert Motions to Exclude the Opinions of Ravgen's Damages Expert Julie Knox and Ravgen's Expert Paul J. Riley by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits W-Z, # 2 Certificate of Service)(Joyce, Alexandra) (Entered: 06/13/2024)
6/13/2024
  • Replyby Δ
[SEALED] REPLY BRIEF re 290 MOTION to Preclude Opinions of Ravgen's Contract Interpretation Expert, Paul J. Riley, Esq., 289 MOTION to Preclude Opinions of Ravgen's Damages Expert, Julie Knox filed by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 06/13/2024)
6/13/2024[SEALED] DECLARATION re 360 Reply Brief,, Declaration of Harry Hanson in Support of Reply Brief in Support of Defendants' Motions for Summary Judgment by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits A-V, # 2 Certificate of Service)(Joyce, Alexandra) (Entered: 06/13/2024)
6/13/2024[SEALED] STATEMENT re 355 Statement, Biora's Response to Ravgen's Statement of Additional Material Facts Regarding Biora's Summary Judgment Motion No. 5 (No Willful Infringement by Biora) by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 06/13/2024)
6/13/2024[SEALED] STATEMENT re 353 Statement Defendants' Response to Ravgen's Statement of Additional Material Facts in Opposition to Defendants' Summary Judgment Motion No. 3 (Non-Infringement) by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 06/13/2024)
6/13/2024[SEALED] STATEMENT re 350 Statement, Defendants' Response to Ravgen's Statement of Additional Material Facts in Opposition to Defendants' Summary Judgment Motion No. 2 (35 U.S.C. Section 112) by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 06/13/2024)
6/13/2024[SEALED] STATEMENT re 346 Statement, 342 Statement, Defendants' Response to Ravgen's Statement of Additional Material Facts in Opposition to Defendants' Summary Judgment Motion No. 1 by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 06/13/2024)
6/13/2024
  • Motion for Summary Judgmentby Δ
[SEALED] REPLY BRIEF re 297 MOTION for Summary Judgment No. 2 that Claims 125 and 132 of U.S. Patent No. 7,332,277 are invalid under 35 U.S.C. Section 112, 300 MOTION for Summary Judgment No. 3 for Non-Infringement of Claims 125 and 132 of U.S. Patent No. 7,332,277, 294 MOTION for Summary Judgment No. 1 that Ravgen's Patent Licence Agreement with Thermo Fisher Released Biora and Roche from Ravgen's Infringment Claims for U.S. Patent No. 7,332,277 as a Matter of Law, 302 MOTION for Summary Judgment No. 5 of No Willful Infringement of Claim 132 of U.S. Patent No. 7,332,277 filed by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 06/13/2024)
6/10/2024359
  • Order
ORAL ORDER Rescheduling Hearing: Due to a conflict on the Court's calendar, the hearing on the pending dispositive and Daubert motions scheduled for July 3, 2024, is RESCHEDULED to August 14, 2024 at 10:00 AM in courtroom 6D. Ordered by Judge Jennifer L. Hall on 6/10/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 06/10/2024)
6/4/2024
  • Order
SO ORDERED, re (458 in 1:20-cv-01646-JLH, 357 in 1:20-cv-01734-JLH) Stipulation and Order to Extend Time to submit public versions of responsive case dispositive and Daubert papers to June 20, 2024. Signed by Judge Jennifer L. Hall on 6/4/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 06/04/2024)
6/4/2024 STIPULATION TO EXTEND TIME to submit public versions of responsive case dispositive and daubert papers to June 20, 2024 - filed by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 06/04/2024)
5/31/2024CORRECTING ENTRY: The pdf for D.I. 308 -2 (Exhibits 49-70) & D.I. 309 -1 (Exhibits 71-85) have been replaced with corrected versions to include missing pages cited in the briefs inadvertently omitted at the initial time of filing. (ceg) (Entered: 05/31/2024)
5/31/2024
  • Order
SO ORDERED, re (336 in 1:20-cv-01734-JLH, 431 in 1:20-cv-01646-JLH) Stipulation and Order Regarding Affirmative Defenses. (*See Order for details). Signed by Judge Jennifer L. Hall on 5/31/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 05/31/2024)
5/30/2024[SEALED] STATEMENT Plaintiff's Statement of Additional Material Facts in Opposition to Defendants' Summary Judgment Motion No. 5 (Biora Willful Infringement) by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 05/30/2024)
5/30/2024[SEALED] STATEMENT re 303 Statement Plaintiff's Response to Defendants' Concise Statement of Facts in Support of Summary Judgment Motion No. 5 (Biora Willful Infringement) by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 05/30/2024)
5/30/2024[SEALED] STATEMENT Plaintiff's Statement of Additional Material Facts in Opposition to Defendants' Summary Judgment Motion No. 3 by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 05/30/2024)
5/30/2024[SEALED] STATEMENT re (385 in 1:20-cv-01646-JLH) Statement, (301 in 1:20-cv-01734-JLH) Statement Plaintiff's Response to Defendants' Concise Statement of Facts in Support of Summary Judgment Motion No. 3 (Noninfringement) by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 05/30/2024)
5/30/2024[SEALED] DECLARATION re 345 Answering Brief in Opposition, Declaration of Harry Hanson by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-10, # 2 Exhibits 11-39, # 3 Certificate of Service)(Joyce, Alexandra) (Entered: 05/30/2024)
5/30/2024[SEALED] STATEMENT Plaintiff's Statement of Additional Material Facts in Opposition to Defendants' Summary Judgment Motion No. 2 (35 U.S.C. § 112) by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 05/30/2024)
5/30/2024[SEALED] STATEMENT re 293 Statement, Roche's and Biora's Counterstatement of Material Facts by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/30/2024)
5/30/2024 STATEMENT re (299 in 1:20-cv-01734-JLH) Statement, (383 in 1:20-cv-01646-JLH) Statement, Plaintiff's Response to Defendants' Concise Statement of Facts In Support of Summary Judgment Motion No. 2 (35 U.S.C. § 112) by Ravgen, Inc.. (Farnan, Brian) (Entered: 05/30/2024)
5/30/2024[SEALED] STATEMENT re 293 Statement, Defendants' Response to Ravgen's Statement of Material Facts in Support of its Motion for Summary Judgment of No Inequitable Conduct and No Unclean Hands by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/30/2024)
5/30/2024[SEALED] STATEMENT re (381 in 1:20-cv-01646-JLH) Statement, (296 in 1:20-cv-01734-JLH) Statement, Plaintiff's Response to Defendants' Concise Statement of Facts in Support of Summary Judgment Motion No. 1 (License) by Ravgen, Inc.. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 05/30/2024)
5/30/2024
  • Motion for Summary Judgmentby Δ
[SEALED] ANSWERING BRIEF in Opposition re 291 MOTION for Summary Judgment of No Inequitable Conduct and No Unclean Hands filed by Biora Therapeutics, Inc..Reply Brief due date per Local Rules is 6/6/2024. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/30/2024)
5/30/2024[SEALED] DECLARATION re 340 Answering Brief in Opposition, Declaration of Harry Hanson by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits 86-90, # 2 Certificate of Service)(Joyce, Alexandra) (Entered: 05/30/2024)
5/30/2024[SEALED] DECLARATION re (339 in 1:20-cv-01734-JLH) Answering Brief in Opposition,,, (440 in 1:20-cv-01646-JLH) Answering Brief in Opposition,,, of Brian Van Ness by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Certificate of Service)(Farnan, Brian) (Entered: 05/30/2024)
5/30/2024[SEALED] STATEMENT re 280 Statement, Defendants' Response to Plaintiff's Statement of Material Facts Regarding Plaintiff's Motion for Summary Judgment of No License and No Release by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/30/2024)
5/30/2024[SEALED] DECLARATION re (339 in 1:20-cv-01734-JLH) Answering Brief in Opposition,,, (440 in 1:20-cv-01646-JLH) Answering Brief in Opposition,,, of Frederick J. Ding by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Exhibit 39, # 40 Exhibit 40, # 41 Exhibit 41, # 42 Exhibit 42, # 43 Exhibit 43, # 44 Exhibit 44, # 45 Exhibit 45, # 46 Exhibit 46, # 47 Exhibit 47, # 48 Certificate of Service)(Farnan, Brian) (Entered: 05/30/2024)
5/30/2024
  • Motion for Summary Judgmentby Δ
[SEALED] ANSWERING BRIEF in Opposition re 277 MOTION for Summary Judgment of No License and No Release filed by Biora Therapeutics, Inc..Reply Brief due date per Local Rules is 6/6/2024. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/30/2024)
5/30/2024
  • Motion for Summary Judgment
[SEALED] ANSWERING BRIEF in Opposition re 297 MOTION for Summary Judgment No. 2 that Claims 125 and 132 of U.S. Patent No. 7,332,277 are invalid under 35 U.S.C. Section 112, 300 MOTION for Summary Judgment No. 3 for Non-Infringement of Claims 125 and 132 of U.S. Patent No. 7,332,277, 294 MOTION for Summary Judgment No. 1 that Ravgen's Patent Licence Agreement with Thermo Fisher Released Biora and Roche from Ravgen's Infringment Claims for U.S. Patent No. 7,332,277 as a Matter of Law, 302 MOTION for Summary Judgment No. 5 of No Willful Infringement of Claim 132 of U.S. Patent No. 7,332,277 filed by Ravgen, Inc..Reply Brief due date per Local Rules is 6/6/2024. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 05/30/2024)
5/30/2024[SEALED] DECLARATION re (337 in 1:20-cv-01734-JLH) Answering Brief in Opposition, (434 in 1:20-cv-01646-JLH) Answering Brief in Opposition, of Jennifer Przybylski by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Certificate of Service)(Farnan, Brian) (Entered: 05/30/2024)
5/30/2024[SEALED] ANSWERING BRIEF in Opposition re 290 MOTION to Preclude Opinions of Ravgen's Contract Interpretation Expert, Paul J. Riley, Esq., 289 MOTION to Preclude Opinions of Ravgen's Damages Expert, Julie Knox filed by Ravgen, Inc..Reply Brief due date per Local Rules is 6/6/2024. (Attachments: # 1 Certificate of Service)(Farnan, Brian) (Entered: 05/30/2024)
5/29/2024
  • Motion
STIPULATION and [Proposed] Order Regarding Affirmative Defenses, by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc. (Haynes, Christine) Modified on 5/30/2024 (ceg). (Entered: 05/29/2024)
5/16/2024REDACTED VERSION of (298 in 1:20-cv-01734-JLH, 390 in 1:20-cv-01646-JLH) Declaration,, by Ravgen, Inc.. (Attachments: # 1 Exhibits 1-3)(Farnan, Michael) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of (295 in 1:20-cv-01734-JLH, 388 in 1:20-cv-01646-JLH) Declaration,,, by Ravgen, Inc.. (Attachments: # 1 Exhibits A-I, # 2 Exhibit J - Part 1 of 2, # 3 Exhibit J - Part 2 of 2, # 4 Exhibits K-N, # 5 Exhibits O-T, # 6 Exhibits U-W, # 7 Exhibits X-AG)(Farnan, Michael) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of (380 in 1:20-cv-01646-JLH, 293 in 1:20-cv-01734-JLH) Statement, by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of (292 in 1:20-cv-01734-JLH) Opening Brief in Support, (378 in 1:20-cv-01646-JLH) Opening Brief in Support by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of (287 in 1:20-cv-01734-JLH, 373 in 1:20-cv-01646-JLH) Declaration, by Ravgen, Inc.. (Attachments: # 1 Exhibits A-K)(Farnan, Michael) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of 311 Exhibit to a Document, by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of 309 Exhibit to a Document, by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits 71-75, # 2 Exhibits 76-85)(Joyce, Alexandra) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of (363 in 1:20-cv-01646-JLH, 280 in 1:20-cv-01734-JLH) Statement, by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of (362 in 1:20-cv-01646-JLH, 279 in 1:20-cv-01734-JLH) Declaration,, by Ravgen, Inc.. (Attachments: # 1 Exhibits A-S)(Farnan, Michael) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of (361 in 1:20-cv-01646-JLH) Opening Brief in Support, (278 in 1:20-cv-01734-JLH) Opening Brief in Support by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of 308 Exhibit to a Document, by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits 21-48, # 2 Exhibits 49-70)(Joyce, Alexandra) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of 307 Declaration,,,,,, by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-5, # 2 Exhibits 6-20)(Joyce, Alexandra) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of 306 Declaration,, by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-15)(Joyce, Alexandra) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of 305 Opening Brief in Support,,, by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of 304 Opening Brief in Support, by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of 303 Statement by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of 301 Statement by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of 299 Statement, by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of 296 Statement, by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 05/16/2024)
5/16/2024REDACTED VERSION of (369 in 1:20-cv-01646-JLH, 283 in 1:20-cv-01734-JLH) Declaration, by Ravgen, Inc.. (Attachments: # 1 Exhibits A-I)(Farnan, Brian) (Entered: 05/16/2024)
5/10/2024Pro Hac Vice Attorney Ashley DaBiere for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (oam) (Entered: 05/10/2024)
5/8/2024
  • Order
SO ORDERED, re (400 in 1:20-cv-01646-JLH, 314 in 1:20-cv-01734-JLH) Motion for Pro Hac Vice Appearance of Attorney Ashley DaBiere filed by Ravgen, Inc. Ordered by Judge Jennifer L. Hall on 5/8/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 05/08/2024)
5/8/2024315Pro Hac Vice Fee - Credit Card Payment received for Ashley DaBiere. ( re 314 MOTION for Pro Hac Vice Appearance of Attorney Ashley DaBiere )( Payment of $ 50, receipt number ADEDC-4403013).(Farnan, Michael) (Entered: 05/08/2024)
5/8/2024
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Ashley DaBiere - filed by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/08/2024)
5/8/2024
  • Order
SO ORDERED, re (312 in 1:20-cv-01734-JLH, 398 in 1:20-cv-01646-JLH) Stipulation and Order to Extend Time to file public versions of the parties' dispositive and Daubert filings to May 16, 2024. Signed by Judge Jennifer L. Hall on 5/8/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 05/08/2024)
5/7/2024 STIPULATION TO EXTEND TIME to file public versions of the parties' dispositive and Daubert filings to May 16, 2024 - filed by Biora Therapeutics, Inc.. (Silver, Daniel) (Entered: 05/07/2024)
5/3/2024[SEALED] EXHIBIT re (307 in 1:20-cv-01734-JLH, 393 in 1:20-cv-01646-JLH) Declaration,,,,,, [Exhibit A to the Declaration of Harry Hanson] by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Haynes, Christine) (Entered: 05/03/2024)
5/3/2024CERTIFICATE OF SERVICE of (i) Plaintiff's Opening Brief in Support of Motion for Summary Judgment of No License and No Release (D.I. 278); (ii) Declaration of Frederick J. Ding (D.I. 279); (iii) Plaintiff's Statement of Material Facts in Support of Motion for Summary Judgment of No License and No Release (D.I. 280); (iv) Declaration of Frederick J. Ding (D.I. 283); (vi) Declaration of Frederick J. Ding (D.I. 287); (vii) Plaintiff's Opening Brief in Support of Motion for Summary Judgment of No Inequitable Conduct and No Unclean Hands (D.I. 292); (viii) Plaintiff's Statement of Material Facts in Support of Motion for Summary Judgment of No Inequitable Conduct and No Unclean Hands (D.I. 293); (ix) Declaration of Ben Nichols (D.I. 295); and (x) Declaration of Brian Van Ness (D.I. 298) by Ravgen, Inc. re 298 Declaration,, 292 Opening Brief in Support, 295 Declaration,,, 283 Declaration, 278 Opening Brief in Support, 287 Declaration, 280 Statement, 279 Declaration,, 293 Statement, (Farnan, Brian) (Entered: 05/03/2024)
5/3/2024DEFICIENCY NOTICE by the Court issued to Ravgen, Inc. re D.I. 278 , 279 , 280 , 283 , 287 , 292 , 295 , 298 . These filings does not comply with Local Rule 5.2(b)(1). Plaintiff is directed to supplement the docket accordingly with a certificate of service. (ceg) (Entered: 05/03/2024)
5/3/2024[SEALED] EXHIBIT re (307 in 1:20-cv-01734-JLH, 393 in 1:20-cv-01646-JLH) Declaration,,,,,, by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # 1 Exhibit 71-85)(Haynes, Christine) (Attachment 1 replaced on 5/31/2024) (ceg). (Entered: 05/03/2024)
5/3/2024[SEALED] EXHIBIT re (307 in 1:20-cv-01734-JLH, 393 in 1:20-cv-01646-JLH) Declaration,,,,,, by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # 1 Exhibit 21-48, # 2 Exhibit 49-70)(Haynes, Christine) (Attachment 2 replaced on 5/31/2024) (ceg). (Entered: 05/03/2024)
5/3/2024[SEALED] DECLARATION re (297 in 1:20-cv-01734-JLH) MOTION for Summary Judgment No. 2 that Claims 125 and 132 of U.S. Patent No. 7,332,277 are invalid under 35 U.S.C. Section 112, (300 in 1:20-cv-01734-JLH) MOTION for Summary Judgment No. 3 for Non-Infringement of Claims 125 and 132 of U.S. Patent No. 7,332,277, (384 in 1:20-cv-01646-JLH) MOTION for Summary Judgment No. 3 for Non-Infringement of Claims 125 and 132 of U.S Patent No. 7,332,277, (382 in 1:20-cv-01646-JLH) MOTION for Summary Judgment No. 2 That Claims 125 and 132 of US Patent No. 7,332,277 are Invalid Under 35 U.S.C. Section 112, (386 in 1:20-cv-01646-JLH) MOTION for Summary Judgment No. 4 of No Willful or Induced Infringement of Claims 125 and 132 of U.S Patent No. 7,332,277, (379 in 1:20-cv-01646-JLH) MOTION for Summary Judgment No. 1 That Ravgen's Patent License Agreement With Thermo Fisher Released Biora and Roche from Ravgen's Infringement Claims for US Patent No. 7,332,277 as a Matter of Law, (294 in 1:20-cv-01734-JLH) MOTION for Summary Judgment No. 1 that Ravgen's Patent Licence Agreement with Thermo Fisher Released Biora and Roche from Ravgen's Infringment Claims for U.S. Patent No. 7,332,277 as a Matter of Law, (302 in 1:20-cv-01734-JLH) MOTION for Summary Judgment No. 5 of No Willful Infringement of Claim 132 of U.S. Patent No. 7,332,277 [Declaration of Harry Hanson] by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # 1 Exhibit 1-20)(Haynes, Christine) (Entered: 05/03/2024)
5/3/2024[SEALED] DECLARATION re (376 in 1:20-cv-01646-JLH, 290 in 1:20-cv-01734-JLH) MOTION to Preclude Opinions of Ravgen's Contract Interpretation Expert, Paul J. Riley, Esq., (375 in 1:20-cv-01646-JLH, 289 in 1:20-cv-01734-JLH) MOTION to Preclude Opinions of Ravgen's Damages Expert, Julie Knox [Declaration of Harry Hanson] by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # 1 Exhibit 1-15)(Haynes, Christine) (Entered: 05/03/2024)
5/3/2024CORRECTING ENTRY: D.I. 306, 307, 308, and 309 have been removed from the docket to be refile at the request of counsel. (ceg) (Entered: 05/03/2024)
5/2/2024[SEALED] OPENING BRIEF in Support re 297 MOTION for Summary Judgment No. 2 that Claims 125 and 132 of U.S. Patent No. 7,332,277 are invalid under 35 U.S.C. Section 112, 300 MOTION for Summary Judgment No. 3 for Non-Infringement of Claims 125 and 132 of U.S. Patent No. 7,332,277, 294 MOTION for Summary Judgment No. 1 that Ravgen's Patent Licence Agreement with Thermo Fisher Released Biora and Roche from Ravgen's Infringment Claims for U.S. Patent No. 7,332,277 as a Matter of Law, 302 MOTION for Summary Judgment No. 5 of No Willful Infringement of Claim 132 of U.S. Patent No. 7,332,277 filed by Biora Therapeutics, Inc..Answering Brief/Response due date per Local Rules is 5/16/2024. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/02/2024)
5/2/2024[SEALED] OPENING BRIEF in Support re 290 MOTION to Preclude Opinions of Ravgen's Contract Interpretation Expert, Paul J. Riley, Esq., 289 MOTION to Preclude Opinions of Ravgen's Damages Expert, Julie Knox filed by Biora Therapeutics, Inc..Answering Brief/Response due date per Local Rules is 5/16/2024. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/02/2024)
5/2/2024[SEALED] STATEMENT re 302 MOTION for Summary Judgment No. 5 of No Willful Infringement of Claim 132 of U.S. Patent No. 7,332,277 by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/02/2024)
5/2/2024
  • Motion for Summary Judgmentby Δ
MOTION for Summary Judgment No. 5 of No Willful Infringement of Claim 132 of U.S. Patent No. 7,332,277 - filed by Biora Therapeutics, Inc.. (Attachments: # 1 Proposed Order)(Joyce, Alexandra) (Entered: 05/02/2024)
5/2/2024[SEALED] STATEMENT re 300 MOTION for Summary Judgment No. 3 for Non-Infringement of Claims 125 and 132 of U.S. Patent No. 7,332,277 by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/02/2024)
5/2/2024
  • Motion for Summary Judgmentby Δ
MOTION for Summary Judgment No. 3 for Non-Infringement of Claims 125 and 132 of U.S. Patent No. 7,332,277 - filed by Biora Therapeutics, Inc.. (Attachments: # 1 Proposed Order)(Joyce, Alexandra) (Entered: 05/02/2024)
5/2/2024[SEALED] STATEMENT re 297 MOTION for Summary Judgment No. 2 that Claims 125 and 132 of U.S. Patent No. 7,332,277 are invalid under 35 U.S.C. Section 112 by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/02/2024)
5/2/2024[SEALED] DECLARATION re (360 in 1:20-cv-01646-JLH) MOTION for Summary Judgment of No License and No Release, (277 in 1:20-cv-01734-JLH) MOTION for Summary Judgment of No License and No Release, (291 in 1:20-cv-01734-JLH) MOTION for Summary Judgment of No Inequitable Conduct and No Unclean Hands, (377 in 1:20-cv-01646-JLH) MOTION for Summary Judgment of No Inequitable Conduct and No Unclean Hands, (284 in 1:20-cv-01734-JLH) Statement, (371 in 1:20-cv-01646-JLH) MOTION for Summary Judgment of No Improper Inventorship of U.S. Patent No. 7,332,277 of Brian Van Ness by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Farnan, Michael) (Entered: 05/02/2024)
5/2/2024
  • Motion for Summary Judgmentby Δ
MOTION for Summary Judgment No. 2 that Claims 125 and 132 of U.S. Patent No. 7,332,277 are invalid under 35 U.S.C. Section 112 - filed by Biora Therapeutics, Inc.. (Attachments: # 1 Proposed Order)(Joyce, Alexandra) (Entered: 05/02/2024)
5/2/2024[SEALED] STATEMENT re 294 MOTION for Summary Judgment No. 1 that Ravgen's Patent Licence Agreement with Thermo Fisher Released Biora and Roche from Ravgen's Infringment Claims for U.S. Patent No. 7,332,277 as a Matter of Law by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Joyce, Alexandra) (Entered: 05/02/2024)
5/2/2024[SEALED] DECLARATION re (378 in 1:20-cv-01646-JLH) Opening Brief in Support, (292 in 1:20-cv-01734-JLH) Opening Brief in Support of Ben Nichols by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J - Part 1 of 2, # 11 Exhibit J - Part 2 of 2, # 12 Exhibit K, # 13 Exhibit L, # 14 Exhibit M, # 15 Exhibit N, # 16 Exhibit O, # 17 Exhibit P, # 18 Exhibit Q, # 19 Exhibit R, # 20 Exhibit S, # 21 Exhibit T, # 22 Exhibit U, # 23 Exhibit V, # 24 Exhibit W, # 25 Exhibit X, # 26 Exhibit Y, # 27 Exhibit Z, # 28 Exhibit AA, # 29 Exhibit AB, # 30 Exhibit AC, # 31 Exhibit AD, # 32 Exhibit AE, # 33 Exhibit AF, # 34 Exhibit AG)(Farnan, Michael) (Entered: 05/02/2024)
5/2/2024
  • Motion for Summary Judgmentby Δ
MOTION for Summary Judgment No. 1 that Ravgen's Patent Licence Agreement with Thermo Fisher Released Biora and Roche from Ravgen's Infringment Claims for U.S. Patent No. 7,332,277 as a Matter of Law - filed by Biora Therapeutics, Inc.. (Attachments: # 1 Proposed Order)(Joyce, Alexandra) (Entered: 05/02/2024)
5/2/2024[SEALED] STATEMENT re (291 in 1:20-cv-01734-JLH) MOTION for Summary Judgment of No Inequitable Conduct and No Unclean Hands, (377 in 1:20-cv-01646-JLH) MOTION for Summary Judgment of No Inequitable Conduct and No Unclean Hands Plaintiff's Statement Of Material Facts In Support Of Motion For Summary Judgment Of No Inequitable Conduct And No Unclean Hands by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/02/2024)
5/2/2024[SEALED] OPENING BRIEF in Support re 291 MOTION for Summary Judgment of No Inequitable Conduct and No Unclean Hands filed by Ravgen, Inc..Answering Brief/Response due date per Local Rules is 5/16/2024. (Farnan, Michael) (Entered: 05/02/2024)
5/2/2024
  • Motion for Summary Judgment
MOTION for Summary Judgment of No Inequitable Conduct and No Unclean Hands - filed by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/02/2024)
5/2/2024
  • Motion
MOTION to Preclude Opinions of Ravgen's Contract Interpretation Expert, Paul J. Riley, Esq. - filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # 1 Text of Proposed Order)(Haynes, Christine) (Entered: 05/02/2024)
5/2/2024
  • Motion
MOTION to Preclude Opinions of Ravgen's Damages Expert, Julie Knox - filed by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # 1 Text of Proposed Order)(Haynes, Christine) (Entered: 05/02/2024)
5/2/2024 STATEMENT re (371 in 1:20-cv-01646-JLH) MOTION for Summary Judgment of No Improper Inventorship of U.S. Patent No. 7,332,277, (285 in 1:20-cv-01734-JLH) MOTION for Summary Judgment of No Improper Inventorship of U.S. Patent No. 7,332,277 Plaintiff's Statement of Material Facts in Support of Motion for Summary Judgment of No Improper Inventorship of U.S. Patent No. 7,332,277 by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/02/2024)
5/2/2024[SEALED] DECLARATION re (286 in 1:20-cv-01734-JLH) Opening Brief in Support, (372 in 1:20-cv-01646-JLH) Opening Brief in Support of Frederick J. Ding by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K)(Farnan, Michael) (Entered: 05/02/2024)
5/2/2024 OPENING BRIEF in Support re 285 MOTION for Summary Judgment of No Improper Inventorship of U.S. Patent No. 7,332,277 filed by Ravgen, Inc..Answering Brief/Response due date per Local Rules is 5/16/2024. (Farnan, Michael) (Entered: 05/02/2024)
5/2/2024
  • Motion for Summary Judgment
MOTION for Summary Judgment of No Improper Inventorship of U.S. Patent No. 7,332,277 - filed by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/02/2024)
5/2/2024 STATEMENT re (367 in 1:20-cv-01646-JLH) MOTION for Summary Judgment of No Equitable Estoppel, No Waiver, and No Acquiescence, (281 in 1:20-cv-01734-JLH) MOTION for Summary Judgment of No Equitable Estoppel, No Waiver, and No Acquiescence Plaintiff's Statement of Material Facts in Support of Motion for Summary Judgment of No Equitable Estoppel, No Waiver, and No Acquiescence by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/02/2024)
5/2/2024[SEALED] DECLARATION re (368 in 1:20-cv-01646-JLH) Opening Brief in Support, (282 in 1:20-cv-01734-JLH) Opening Brief in Support of Frederick J. Ding by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Farnan, Michael) (Entered: 05/02/2024)
5/2/2024 OPENING BRIEF in Support re 281 MOTION for Summary Judgment of No Equitable Estoppel, No Waiver, and No Acquiescence filed by Ravgen, Inc..Answering Brief/Response due date per Local Rules is 5/16/2024. (Farnan, Michael) (Entered: 05/02/2024)
5/2/2024
  • Motion for Summary Judgment
MOTION for Summary Judgment of No Equitable Estoppel, No Waiver, and No Acquiescence - filed by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/02/2024)
5/2/2024[SEALED] STATEMENT re (360 in 1:20-cv-01646-JLH) MOTION for Summary Judgment of No License and No Release, (277 in 1:20-cv-01734-JLH) MOTION for Summary Judgment of No License and No Release Plaintiff's Statement of Material Facts in Support of Motion for Summary Judgment of No License and No Release by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/02/2024)
5/2/2024[SEALED] DECLARATION re (278 in 1:20-cv-01734-JLH) Opening Brief in Support, (361 in 1:20-cv-01646-JLH) Opening Brief in Support of Frederick J. Ding by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S)(Farnan, Michael) (Entered: 05/02/2024)
5/2/2024[SEALED] OPENING BRIEF in Support re 277 MOTION for Summary Judgment of No License and No Release filed by Ravgen, Inc..Answering Brief/Response due date per Local Rules is 5/16/2024. (Farnan, Michael) (Entered: 05/02/2024)
5/2/2024
  • Motion for Summary Judgment
MOTION for Summary Judgment of No License and No Release - filed by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/02/2024)
4/26/2024Remark: D.I. 270 has been unsealed. (lih) (Entered: 04/26/2024)
4/24/2024NOTICE requesting Clerk to remove Julianne Thomsen and Peter Zhu as co-counsel.. (Farnan, Brian) (Entered: 04/24/2024)
4/22/2024
  • Order
SO ORDERED, re (274 in 1:20-cv-01734-JLH, 354 in 1:20-cv-01646-JLH) Stipulated Scheduling Order consistent with the Court's April 12, 2024 Oral Order. Signed by Judge Jennifer L. Hall on 4/22/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Main Document 275 replaced on 4/22/2024) (ceg). (Entered: 04/22/2024)
4/19/2024Joint PROPOSED Scheduling Order, by Ravgen, Inc. (Farnan, Brian) Modified on 4/19/2024 (ceg). (Entered: 04/19/2024)
4/12/2024273
  • Order
ORAL ORDER: Having reviewed the parties' April 9, 2024 letter (No. 20-1646, D.I. 352; No. 20-1734, D.I. 268), IT IS ORDERED THAT the trial sequencing conference currently scheduled for April 22, 2024, is CANCELLED. The jury trial presentations involving Roche shall occur the week of October 28, 2024. The Court requests that the parties consent to jury selection by a United States Magistrate Judge, with jury selection occurring on October 25, 2024. The Court anticipates that it will hear the evidence regarding Defendants' inequitable conduct defense concurrently with the first jury trial outside of the presence of the jury; the Court will make a decision regarding the schedule at the pretrial conference. The Court will schedule the second jury trial after the first trial has concluded. The parties shall file a stipulated proposed schedule effecting the foregoing ruling on or before April 19, 2024. Ordered by Judge Jennifer L. Hall on 4/12/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 04/12/2024)
4/12/2024REDACTED VERSION of 267 Letter, by Biora Therapeutics, Inc.. (Silver, Daniel) (Entered: 04/12/2024)
4/11/2024REDACTED VERSION of 266 Letter, by Ravgen, Inc. (Attachments: # 1 Text of Proposed Order, # 2 Exhibits 1-28)(Farnan, Michael) Modified on 4/11/2024 (ceg). (Entered: 04/11/2024)
4/11/2024
  • Order
MEMORANDUM ORDER- re 256 MOTION for Teleconference to Resolve Discovery Dispute. Signed by Judge Sherry R. Fallon on 4/11/2024.This order has been emailed to local counsel. (lih) (Entered: 04/11/2024)
4/11/2024269
  • Order
ORAL ORDER- re 256 Motion for Teleconference to Resolve Discovery Dispute: The parties have presented a dispute about the application of the attorney-client privilege and work product protection. The focus of the Court's analysis is on the documents submitted for in camera review, and the Court is prepared to issue a ruling on the papers submitted. Therefore, IT IS ORDERED that the discovery dispute teleconference scheduled for April 11, 2024 at 10:00 a.m. is CANCELLED. A Memorandum Order will issue today addressing the parties' disputes. Ordered by Judge Sherry R. Fallon on 4/11/2024. (lih) (Entered: 04/11/2024)
4/9/2024 Letter to The Honorable Jennifer L. Hall from Brian E. Farnan regarding Joint Status Letter regarding Trial Order and Schedule. (Farnan, Brian) (Entered: 04/09/2024)
4/5/2024[SEALED] Letter to The Honorable Sherry R. Fallon from Daniel M. Silver regarding Response to Discovery Dispute on Privilege Log. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Certificate of Service)(Silver, Daniel) (Entered: 04/05/2024)
4/4/2024[SEALED] Letter to The Honorable Sherry R. Fallon from Michael J. Farnan regarding Opening Discovery Dispute Letter. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit 1, # 3 Exhibit 2, # 4 Exhibit 3, # 5 Exhibit 4, # 6 Exhibit 5, # 7 Exhibit 6, # 8 Exhibit 7, # 9 Exhibit 8, # 10 Exhibit 9, # 11 Exhibit 10, # 12 Exhibit 11, # 13 Exhibit 12, # 14 Exhibit 13, # 15 Exhibit 14, # 16 Exhibit 15, # 17 Exhibit 16, # 18 Exhibit 17, # 19 Exhibit 18, # 20 Exhibit 19, # 21 Exhibit 20, # 22 Exhibit 21, # 23 Exhibit 22, # 24 Exhibit 23, # 25 Exhibit 24, # 26 Exhibit 25, # 27 Exhibit 26, # 28 Exhibit 27, # 29 Exhibit 28)(Farnan, Michael) (Entered: 04/04/2024)
4/2/2024265
  • Order
ORAL ORDER: Having reviewed the parties' Joint Status Letter Regarding Dispositive and Daubert Motion Page Limits (C.A. No. 20-1646, D.I. 350; C.A. No. 20-1734, D.I. 264), IT IS ORDERED that the briefing page limits shall be 60+60+30 per side. IT IS FURTHER ORDERED that the parties are not required to rank their summary judgment and Daubert motions. Ordered by Judge Jennifer L. Hall on 4/2/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 04/02/2024)
3/25/2024Joint Letter to The Honorable Jennifer L. Hall from Brian E. Farnan regarding Dispositive and Daubert Motion Page Limits. (Farnan, Brian) (Entered: 03/25/2024)
3/20/2024
  • Order
SO ORDERED, re (348 in 1:20-cv-01646-JLH, 262 in 1:20-cv-01734-JLH) Stipulation and Order to Extend Time to file a Joint Status Letter Regarding Dispositive and Daubert Motion Page Limits to March 25, 2024. Signed by Judge Jennifer L. Hall on 3/20/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 03/20/2024)
3/20/2024 STIPULATION and [Proposed] Order to Extend Time for the parties to file a Joint Letter Regarding Dispositive and Daubert Motion Page Limits to March 25, 2024 - filed by Ravgen, Inc. (Farnan, Michael) Modified on 3/20/2024 (ceg). (Entered: 03/20/2024)
3/13/2024261
  • Order
SO ORDERED, re 256 MOTION for Teleconference to Resolve Discovery Dispute. A Discovery Dispute Motion Hearing is set for 4/11/2024 at 10:00 AM before Judge Sherry R. Fallon. In preparation for this hearing the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Order regarding discovery matters available at www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. The plaintiff should obtain court reporting services for the conference, with the cost to be shared equally between both sides. No later than 4/10/2024 at 10:00 a.m., the parties shall send a joint email to Larisha_Hicks@ded.uscourts.gov containing (i) the name of the court reporter; (ii) the name of the court reporting agency; and (iii) confirmation that the court reporter has been provided with the court's AT&T dial-in information. The Court may choose to resolve the disputes prior to the telephone conference and will, in that event, cancel the conference. Set Deadlines: (Moving submission due 4/4/2024, Responsive submission due 4/5/2024). IT IS FURTHER ORDERED that, on or before April 4, 2024, defendant shall submit two copies of the disputed privilege log entries to the Court in a clearly marked, sealed envelope for in camera review. Signed by Judge Sherry R. Fallon on 3/13/2024. (Polito, Rebecca) (Entered: 03/13/2024)
3/13/2024260
  • Order
ORAL ORDER REFERRING MOTION: IT IS HEREBY ORDERED that the Motion for Teleconference to Resolve Discovery Dispute (D.I. 256 ) is now REFERRED to Magistrate Judge Sherry R. Fallon. Ordered by Judge Jennifer L. Hall on 3/13/2024. (ceg) (Entered: 03/13/2024)
3/12/2024 Letter to The Honorable Jennifer L. Hall from Daniel M. Silver regarding request for discovery teleconference. (Silver, Daniel) Modified on 3/12/2024 (ceg). (Entered: 03/12/2024)
3/12/2024 Letter to The Honorable Jennifer L. Hall from Michael J. Farnan regarding Response to Biora's March 11, 2024 Letter. (Farnan, Michael) Modified on 3/12/2024 (ceg). (Entered: 03/12/2024)
3/11/2024 Letter to The Honorable Jennifer L. Hall from Daniel M. Silver regarding response to Plaintiff's motion for a discovery teleconference. (Silver, Daniel) Modified on 3/11/2024 (ceg). (Entered: 03/11/2024)
3/11/2024
  • Motion
MOTION for Teleconference to Resolve Discovery Dispute - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 03/11/2024)
3/11/2024
  • Motion to Appear Pro Hac Vice
SO ORDERED, re 254 Motion for Pro Hac Vice Appearance of Attorney Arthur W. Coviello filed by Biora Therapeutics, Inc. Ordered by Judge Jennifer L. Hall on 3/11/2024. (ceg) (Entered: 03/11/2024)
3/8/2024255Pro Hac Vice Fee - Credit Card Payment received for Arthur W. Coviello. ( re 254 MOTION for Pro Hac Vice Appearance of Attorney Arthur W. Coviello )( Payment of $ 50, receipt number ADEDC-4357444).(Silver, Daniel) (Entered: 03/08/2024)
3/8/2024
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Arthur W. Coviello - filed by Biora Therapeutics, Inc.. (Silver, Daniel) (Entered: 03/08/2024)
3/8/2024NOTICE OF SERVICE of (1) Reply Expert Report and Disclosure of Julie L. Davis Regarding Commercial Success, (2) Reply Expert Report of Stacey Gabriel, Ph.D. Regarding U.S. Patent No. 7,332,277, (3) Reply Expert Report of Michael Metzker, Ph.D., and (4) Reply Expert Report of Stephan Vigues, Ph.D. filed by Biora Therapeutics, Inc..(Silver, Daniel) (Entered: 03/08/2024)
3/8/2024NOTICE OF SERVICE of (i) Reply Expert Report of Brian Van Ness, Ph.D. concerning Biora Therapeutics, Inc.'s Infringement of U.S. Patent No. 7,332,277 and (ii) Expert Reply Report of Julie H. Knox filed by Ravgen, Inc..(Farnan, Brian) (Entered: 03/08/2024)
2/21/2024
  • Order
SO ORDERED, re (250 in 1:20-cv-01734-JLH, 342 in 1:20-cv-01646-JLH) Stipulation and Order to Extend Time to file a Joint Status Letter Regarding Dispositive and Daubert Motion Page Limits to March 21, 2024. Signed by Judge Jennifer L. Hall on 2/21/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 02/21/2024)
2/21/2024 STIPULATION TO EXTEND TIME to file a Joint Status Letter Regarding Dispositive and Daubert Motion Page Limits to March 21, 2024 - filed by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 02/21/2024)
2/20/2024NOTICE OF SERVICE of Biora's First Amended Responses and Objections to Plaintiffs' First Set of Requests for Admissions Nos. 1-50 filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 02/20/2024)
2/20/2024NOTICE OF SERVICE of Plaintiff's Second Amended Objections and Responses to Defendant Biora Therapeutics, Inc.'s First Set of Requests for Admission (Nos. 1-50) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 02/20/2024)
2/13/2024NOTICE OF SERVICE of (i) Expert Report of Julie H. Knox on Commercial Success; (ii) Rebuttal Expert Report of Brian Van Ness, Ph.D. Regarding the Validity of U.S. Patent No. 7,332,277; and (iii) Rebuttal Expert Report of Garth D. Ehrlich, Ph.D. filed by Ravgen, Inc..(Farnan, Brian) (Entered: 02/13/2024)
2/13/2024NOTICE OF SERVICE of (1) Rebuttal Expert Report and Disclosure of Julie L. Davis, and (2) Rebuttal Expert Report of Jason Acker, Ph.D. regarding U.S. Patent No. 7,33,277 filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 02/13/2024)
2/9/2024NOTICE OF SERVICE of Defendant Biora Therapeutics, Inc.'s Identification of Prior Art References filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 02/09/2024)
2/9/2024NOTICE OF SERVICE of Ravgen's Supplemental Identification of Asserted Patents and Accused Products filed by Ravgen, Inc..(Farnan, Brian) (Entered: 02/09/2024)
2/2/2024
  • Order
SO ORDERED, re (336 in 1:20-cv-01646-JLH, 242 in 1:20-cv-01734-JLH) Stipulation and Order to Extend the deadline to Serve Rebuttal Expert Reports to February 12, 2024. Ordered by Judge Jennifer L. Hall on 2/2/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 02/02/2024)
2/2/2024
  • Motion to Extend Timeby Δ
STIPULATION TO EXTEND TIME the Deadline to Serve Rebuttal Expert Reports to February 12, 2024 - filed by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 02/02/2024)
2/1/2024NOTICE to Take Deposition of Ravgen, Inc. on February 7, 2024 filed by Biora Therapeutics, Inc..(Silver, Daniel) (Entered: 02/01/2024)
1/26/2024NOTICE OF SERVICE of Plaintiff Ravgen Inc.'s Objections and Responses to Defendant's January 19, 2024 Notice of Deposition to Ravgen, Inc. filed by Ravgen, Inc..(Farnan, Brian) (Entered: 01/26/2024)
1/26/2024
  • Motion for Claim Construction
CLAIM CONSTRUCTION ORDER. Signed by Judge Jennifer L. Hall on 1/26/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 01/26/2024)
1/26/2024 PROPOSED Claim Construction Order by Ravgen, Inc. (Attachments: # 1 Letter to The Honorable Jennifer L. Hall) (Farnan, Michael) Modified on 1/26/2024 (ceg). (Entered: 01/26/2024)
1/22/2024
  • Order
ORDER: IT IS HEREBY ORDERED that the disputed claim terms shall be construed as set forth in D.I. 205. The parties shall prepare and file a Claim Construction Order for the Courts signature that sets forth those constructions. To the extent it is necessary, the parties Objections (D.I. 212, 235) are OVERRULED. Signed by Judge Jennifer L. Hall on 1/22/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 01/22/2024)
1/22/2024
  • Order
SO ORDERED, re (234 in 1:20-cv-01734-JLH, 327 in 1:20-cv-01646-JLH) Stipulation and Order Extending Case Schedule. (*Resetting Scheduling Order Deadlines: Rebuttal Expert Reports due by 2/8/2024; Reply Expert Reports due by 3/7/2024; Expert Discovery due by 4/11/2024; Dispositive Motions due by 5/2/2024; Answering Brief due 5/30/2024; Reply Brief due 6/13/2024; A Motion Hearing is set for 7/3/2024 at 01:00 PM in Courtroom 6D before Judge Jennifer L. Hall). Ordered by Judge Jennifer L. Hall on 1/22/2024. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 01/22/2024)
1/17/2024
  • Order
SO ORDERED, re (235 in 1:20-cv-01734-JLH, 328 in 1:20-cv-01646-JLH) Joint Stipulation Regarding Admissibility of Documents. Signed by Judge Jennifer L. Hall on 1/17/202. Associated Cases: 1:20-cv-01646-JLH, 1:20-cv-01734-JLH(ceg) (Entered: 01/17/2024)
1/15/2024Joint STIPULATION Regarding Admissibility of Documents by Ravgen, Inc.. (Farnan, Brian) (Entered: 01/15/2024)
1/12/2024 STIPULATION Extending Case Schedule by Ariosa Diagnostics, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Haynes, Christine) (Entered: 01/12/2024)
1/9/2024Case Reassigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (nms) (Entered: 01/09/2024)
1/9/2024 Case no longer referred to Judge Jennifer L. Hall (m). (nms) (Entered: 01/09/2024)
12/13/2023
  • Order
SO ORDERED, re (323 in 1:20-cv-01646-RGA-JLH, 230 in 1:20-cv-01734-RGA-JLH) Stipulation for Leave to Conduct the Deposition of Third Party Matthew Sobansky Outside of Fact Discovery. Signed by Judge Jennifer L. Hall on 12/13/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 12/13/2023)
12/8/2023NOTICE OF SERVICE of (1) Opening Expert Report of Stacey Gabriel, Ph.D. regarding U.S. Patent No. 7,332,277, (2) Opening Expert Report of Stephan Vigues, Ph.D., and (3) Opening Expert Report of Michael Metzker, Ph.D filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 12/08/2023)
12/8/2023NOTICE OF SERVICE of (i) Opening Expert Report of Dr. Glenn D. Prestwich, Ph.D.; (ii) Opening Expert Report of Keith A. Eddleman, M.D.; (iii) Opening Expert Report of Brian Van Ness, Ph.D. Concerning Biora Therapeutics, Inc.s Infringement of U.S. Patent No. 7,332,277; (iv) Expert Report of Julie H. Knox; (v) Opening Expert Report of Paul J. Riley Concerning the Thermo Fisher and Ravgen Patent License Agreement; and (vi) Opening Expert Report of Dr. John Williams, Ph.D. filed by Ravgen, Inc..(Farnan, Brian) (Entered: 12/08/2023)
12/7/2023
  • Motion
STIPULATION for Leave to Conduct the Deposition of Third Party Matthew Sobansky Outside of Fact Discovery by Ravgen, Inc.. (Farnan, Brian) (Entered: 12/07/2023)
12/7/2023NOTICE OF SERVICE of (1) Defendant Biora Therapeutics, Inc.'s Supplemental Responses and Objections to Plaintiff Ravgen, Inc.'s First Set of Common Interrogatories to Defendants (Nos. 1-15), (2) Defendant Biora Therapeutics, Inc.'s Supplemental Responses and Objections to Plaintiff Ravgen, Inc.'s Second Set of Common Interrogatories to Defendants (Nos. 16-18), and (3) Defendant Biora Therapeutics, Inc.'s Supplemental Responses and Objections to Plaintiff Ravgen, Inc.'s First Set of Individual Interrogatories to Defendants (Nos. 1-3) filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 12/07/2023)
11/20/2023228
  • Order
ORAL ORDER: Having reviewed the documents Ravgen submitted for in camera review and the accompanying privilege log, the Court finds that Ravgen has met its burden of showing the applicability of the attorney-client privilege and/or the common interest privilege for all documents submitted except document 01284. Document 01284 shall be produced no later than November 22, 2023. Ordered by Judge Jennifer L. Hall on 11/20/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 11/20/2023)
11/17/2023NOTICE OF SERVICE of Defendant Biora Therapeutics, Inc.'s Second Amended Invalidity Contentions with Respect to U.S. Patent No. 7,332,277 filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 11/17/2023)
11/13/2023REDACTED VERSION of 223 Letter, by Biora Therapeutics, Inc.. (Joyce, Alexandra) Modified on 11/14/2023 (nms). (Entered: 11/13/2023)
11/9/2023REDACTED VERSION of 221 Letter, by Ravgen, Inc.. (Attachments: # 1 Exhibits 1-11)(Farnan, Michael) Modified on 11/9/2023 (nms). (Entered: 11/09/2023)
11/8/2023224
  • Order
ORAL ORDER: Having reviewed the parties' discovery motions and letters (C.A. No. 20-1646, D.I. 304, 308, 309, 310, 311; C.A. No. 20-1734, D.I. 218, 221, 223), IT IS HEREBY ORDERED that Ravgen's motion to compel is DENIED: (1) the Court is not persuaded that the requested discovery is within the possession, custody, or control of Defendants, (2) nor is the Court persuaded that the requested discovery is relevant and non-cumulative given that Ravgen already possesses the terms of Dr. Holzgreve's agreements related to this case. IT IS FURTHER ORDERED that Defendants' discovery motion is GRANTED-IN-PART, as follows: by no later than November 9, 2023, at noon, Ravgen shall (1) update its privilege log to identify the specific attorneys and/or firms associated with the challenged communications, and (2) submit a copy of the updated privilege log along with hard copy versions of the following documents for in camera review by the Court: 01214, 01215, 01216, 01217, 01218, 01219, 01220, 01221, 01284, 01292, 01293, 01294, 01295, 00001, 00002, 00122, 00123, 00124, 00125, 00128, 00129, 00131, 00132, 00361, 00362, 00376, 00377, 00751, 00752, 00753, 00802, 00803, 00804, 00805, 01020, 01173, 01178, 01179, 01275, 01276. IT IS FURTHER ORDERED that the discovery dispute teleconference scheduled for November 8, 2023 is CANCELLED. Ordered by Judge Jennifer L. Hall on 11/8/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 11/08/2023)
11/6/2023[SEALED] Letter to The Honorable Jennifer L. Hall, from Defendants, regarding response to Plaintiffs' November 2, 2023 letter. (Attachments: # 1 Exhibits A-G, # 2 Certificate of Service)(Joyce, Alexandra) Modified on 11/7/2023 (nms). (Entered: 11/06/2023)
11/3/2023NOTICE OF SERVICE of Defendant Biora Therapeutics, Inc.'s Fourth Amended Rule 26(a)(1) Disclosures filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 11/03/2023)
11/2/2023[SEALED] Letter to The Honorable Jennifer L. Hall from Michael J. Farnan regarding Discovery Dispute. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11)(Farnan, Michael) (Entered: 11/02/2023)
10/31/2023220
  • Order
ORAL ORDER Setting Teleconference: The Court has reviewed the Motions for Teleconference to Resolve Discovery Disputes (C.A. 20-1646, D.I. 302 & D.I. 304; C.A. 20-1734, D.I. 218). A discovery dispute teleconference is scheduled for November 8, 2023 at 3:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than November 2, 2023, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than November 6, 2023, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 10/31/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) Modified on 11/8/2023 (ceg). (Entered: 10/31/2023)
10/30/2023NOTICE OF SERVICE of Plaintiff's Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 10/30/2023)
10/30/2023
  • Order
SO ORDERED, re (299 in 1:20-cv-01646-RGA-JLH, 215 in 1:20-cv-01734-RGA-JLH) Stipulation Extending Deadline for Certain Fact Depositions. Ordered by Judge Jennifer L. Hall on 10/30/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 10/30/2023)
10/27/2023
  • Motion
MOTION for Teleconference to Resolve Discovery Dispute - filed by Ravgen, Inc. Motions referred to Jennifer L. Hall. (Farnan, Michael) Modified on 10/30/2023 (ceg). (Entered: 10/27/2023)
10/27/2023NOTICE OF SERVICE of (1) Defendant Biora Therapeutics, Inc.'s Supplemental Responses and Objections to Plaintiff Ravgen Inc.'s First Set of Individual Interrogatories to Defendant Biora Therapeutics, Inc. (Nos. 1-3), (2) Defendant Biora Therapeutics, Inc.'s Supplemental Responses and Objections to Plaintiff Ravgen Inc.'s First Set of Common Interrogatories to Defendants (Nos. 1-15), and (3) Defendant Biora Therapeutics, Inc.'s Supplemental Responses and Objections to Plaintiff Ravgen Inc.'s Second Set of Common Interrogatories to Defendants (Nos. 16-18) filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 10/27/2023)
10/27/2023NOTICE OF SERVICE of (i) Plaintiff Ravgen's First Supplemental Responses To Biora Therapeutics' First Set Of Individual Interrogatories (Nos. 1-4); (ii) Plaintiff Ravgen's First Supplemental Responses To Defendants' Second Set Of Common Interrogatories (Nos. 15-16); and (iii) Plaintiff Ravgen's Third Supplemental Responses to Defendants' First Set Of Common Interrogatories (Nos. 1-14) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 10/27/2023)
10/27/2023
  • Motion
STIPULATION Extending Deadline for Certain Fact Depositions - filed by Ravgen, Inc. (Farnan, Brian) Modified on 10/27/2023 (ceg). (Entered: 10/27/2023)
10/27/2023NOTICE OF SERVICE of Plaintiff's Amended Objections and Responses to Defendant Biora Therapeutics, Inc.'s First Set of Requests for Admission (Nos. 1-50) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 10/27/2023)
10/24/2023NOTICE OF SERVICE of Defendant Biora Therapeutics, Inc.'s Third Amended Rule 26(a)(1) Disclosures filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 10/24/2023)
9/25/2023NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendant Biora Therapeutics, Inc.'s First Set of Requests for Admission (Nos. 1-50) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/25/2023)
9/25/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Responses to Defendants' Third Set of Common Interrogatories (Nos. 17-20) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/25/2023)
9/25/2023NOTICE OF SERVICE of (1) Defendant Biora Therapeutics, Inc.'s Responses and Objections to Plaintiff Ravgen, Inc.'s Third Set of Common Interrogatories to Defendants (Nos. 19-20), and (2) Defendant Biora Therapeutics, Inc.'s Response and Objections to Plaintiff Ravgen, Inc.'s First Set of Requests for Admission (Nos. 1-50) filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 09/25/2023)
9/22/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Second Supplemental Responses to Defendants' First Set of Common Interrogatories (Nos. 1-14) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/22/2023)
9/20/2023 NOTICE of Subpoena to Onkar Singh by Biora Therapeutics, Inc. (Joyce, Alexandra) (Entered: 09/20/2023)
9/20/2023Pro Hac Vice Attorney Kevin Goon,Gillian F. Moore for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 09/20/2023)
9/19/2023
  • Order
SO ORDERED, re (291 in 1:20-cv-01646-RGA-JLH, 215 in 1:20-cv-01730-RGA-JLH, 207 in 1:20-cv-01734-RGA-JLH) Motion for Pro Hac Vice Appearance of Attorney Gillian F. Moore and Kevin Goon filed by Ravgen, Inc. Ordered by Judge Jennifer L. Hall on 9/19/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 09/19/2023)
9/19/2023
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Gillian F. Moore and Kevin Goon - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Michael) (Entered: 09/19/2023)
9/15/2023NOTICE OF SERVICE of Responses and Objections to Plaintiff's Second Set of Common Interrogatories (Nos. 16-18) filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 09/15/2023)
9/14/2023
  • Order
SO ORDERED, re (211 in 1:20-cv-01730-RGA-JLH, 204 in 1:20-cv-01734-RGA-JLH, 286 in 1:20-cv-01646-RGA-JLH) Stipulation Extending Case Schedule. (*Reset Scheduling Order Deadlines: Fact Discovery completed by 10/27/2023; Opening Expert Reports due by 12/7/2023; Rebuttal Expert Reports due by 1/25/2024; Reply Expert Reports due by 2/22/2024; Expert Discovery due by 3/14/2024). Ordered by Judge Jennifer L. Hall on 9/14/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 09/14/2023)
9/13/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Amended Privilege Log filed by Ravgen, Inc..(Farnan, Brian) (Entered: 09/13/2023)
9/8/2023STIPULATION Extending Case Schedule, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Haynes, Christine) (Entered: 09/08/2023)
9/8/2023203
  • Order
ORAL ORDER: Defendants' Motion to Set an Early Inequitable Conduct Trial (C.A. No. 20-1646, D.I. 234; C.A. No. 20-1730, D.I. 157; C.A. No. 20-1734, D.I. 167) is DENIED. The Court is not persuaded under the circumstances that holding an inequitable conduct bench trial a year before the scheduled jury trial is the most efficient way to proceed with these cases. Ordered by Judge Jennifer L. Hall on 9/8/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 09/08/2023)
9/5/2023REDACTED VERSION of 199 Reply Brief, by Biora Therapeutics, Inc.. (Joyce, Alexandra) Modified on 9/5/2023 (nms). (Entered: 09/05/2023)
9/5/2023
  • Motion to Appear Pro Hac Vice
SO ORDERED, 198 MOTION for Pro Hac Vice Appearance of Attorney Kevin S. Prussia, 200 MOTION for Pro Hac Vice Appearance of Attorney Michaela Sewall, 201 MOTION for Pro Hac Vice Appearance of Attorney Jordan L. Hirsch filed by Biora Therapeutics, Inc. Ordered by Judge Jennifer L. Hall on 9/5/2023. (ceg) (Entered: 09/05/2023)
8/30/2023
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Jordan L. Hirsch - filed by Biora Therapeutics, Inc.. Motions referred to Jennifer L. Hall.(Joyce, Alexandra) (Entered: 08/30/2023)
8/30/2023
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Michaela Sewall - filed by Biora Therapeutics, Inc.. Motions referred to Jennifer L. Hall.(Joyce, Alexandra) (Entered: 08/30/2023)
8/29/2023CORRECTING ENTRY: Attachment 1 to D.I. 199 has been replaced with corrected document per the filer's request. The NEF's have been regenerated. (lah) (Entered: 08/29/2023)
8/28/2023
  • Reply
[SEALED] REPLY BRIEF re 167 MOTION to Set an Inequitable Conduct Trial filed by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits 1-4, # 2 Certificate of Service)(Joyce, Alexandra) (Attachment 1 replaced on 8/29/2023) (lah). (Entered: 08/28/2023)
8/25/2023
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Kevin S. Prussia - filed by Biora Therapeutics, Inc.. Motions referred to Jennifer L. Hall.(Joyce, Alexandra) (Entered: 08/25/2023)
8/23/2023NOTICE OF SERVICE of Defendant Biora Therapeutics, Inc.'s First Set of Requests for Admission to Plaintiff Ravgen, Inc. (Nos. 1-50) filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 08/23/2023)
8/23/2023NOTICE OF SERVICE of Defendants' Third Set of Common Interrogatories to Plaintiff Ravgen, Inc. (Nos. 17-20) filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 08/23/2023)
8/23/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Second Set of Requests for Admission (Authentication) to Biora Therapeutics, Inc. (Nos. 51172) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/23/2023)
8/23/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Third Set of Common Interrogatories to Defendants (Nos. 19-20) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/23/2023)
8/22/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Set of Requests for Admission to Biora Therapeutics, Inc. (Nos. 1-50) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/22/2023)
8/21/2023 NOTICE of Subpoenas by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Farnan, Brian) (Entered: 08/21/2023)
8/21/2023NOTICE OF SERVICE of Privilege Log filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 08/21/2023)
8/18/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Privilege Log filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/18/2023)
8/18/2023
  • Order
SO ORDERED, re (268 in 1:20-cv-01646-RGA-JLH, 193 in 1:20-cv-01730-RGA-JLH, 188 in 1:20-cv-01734-RGA-JLH) Stipulation and Order to Extend Time to file a Reply Brief in Support of Motion to Set an Inequitable Conduct Trial to August 28, 2023. (*Reset Briefing Deadline: Reply Brief due 8/28/2023). Ordered by Judge Jennifer L. Hall on 8/18/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 08/18/2023)
8/18/2023189
  • Order
ORAL ORDER: Having reviewed the parties' letters (C.A. No. 20-1646, D.I. 262, 266; C.A. No. 20-1730, D.I. 189, 192; C.A. No. 20-1734, D.I. 185, 187), the Court is not convinced that it is appropriate to order case narrowing prior to the issuance of the claim construction order. Accordingly, IT IS HEREBY ORDERED that the discovery motion (C.A. No. 20-1646, D.I. 241; C.A. No. 20-1730, D.I. 171; C.A. No. 20-1734, D.I. 170) is DENIED without prejudice to re-raise after issuance of the claim construction order. The parties must meet and confer prior to a subsequent discovery motion raising this issue. The parties are encouraged to continue working towards narrowing the case in the interim. Accordingly, the teleconference scheduled for August 18, 2023 at 3:00 pm is CANCELLED. Ordered by Judge Jennifer L. Hall on 8/18/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 08/18/2023)
8/17/2023 STIPULATION and Proposed Order to Extend Time to file a Reply Brief in Support of Motion to Set an Inequitable Conduct Trial to August 28, 2023 - filed by Biora Therapeutics, Inc.. (Joyce, Alexandra) Modified on 8/18/2023 (nms). (Entered: 08/17/2023)
8/16/2023 Letter to The Honorable Jennifer L. Hall, from Michael J. Farnan, regarding response to Defendants' August 14, 2023, letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Michael) Modified on 8/16/2023 (nms). (Entered: 08/16/2023)
8/16/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Second Set of Common Interrogatories to Defendants (Nos. 16-18) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/16/2023)
8/14/2023 Letter to The Honorable Jennifer L. Hall, from Daniel M. Silver, regarding discovery dispute on claim narrowing. (Attachments: # 1 Proposed Order, # 2 Exhibits 1-5)(Silver, Daniel) Modified on 8/15/2023 (nms). (Entered: 08/14/2023)
8/14/2023
  • Response
RESPONSE to 168 by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Haynes, Christine) Modified on 8/15/2023 (nms). (Entered: 08/14/2023)
8/14/2023 DECLARATION of Julianne Thomsen re 182 Answering Brief in Opposition by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6) (Farnan, Brian) Modified on 8/14/2023 (ceg). Modified on 8/15/2023 (nms). (Entered: 08/14/2023)
8/14/2023 ANSWERING BRIEF in Opposition re 167 MOTION to Set an Inequitable Conduct Trial filed by Ravgen, Inc..Reply Brief due date per Local Rules is 8/21/2023. (Farnan, Brian) (Entered: 08/14/2023)
8/11/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Responses to Defendants' Second Set of Common Interrogatories (Nos. 15-16) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/11/2023)
8/10/2023 NOTICE of Subpoenas by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Farnan, Brian) (Entered: 08/10/2023)
8/9/2023Pro Hac Vice Attorney Jennifer M. Przybylski for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) (Entered: 08/09/2023)
8/9/2023 NOTICE of Subpoena to Deborah S. Kipp by Ravgen, Inc. (Attachments: # 1 Exhibit 1)(Farnan, Brian) (Entered: 08/09/2023)
8/9/2023
  • Order
SO ORDERED, re (253 in 1:20-cv-01646-RGA-JLH, 180 in 1:20-cv-01730-RGA-JLH, 178 in 1:20-cv-01734-RGA-JLH) Motion for Pro Hac Vice Appearance of Attorney Jennifer Przybylski filed by Ravgen, Inc. Ordered by Judge Jennifer L. Hall on 8/9/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 08/09/2023)
8/8/2023
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Jennifer Przybylski - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Brian) (Entered: 08/08/2023)
8/7/2023 NOTICE of Subpoena to Harry Stylli by Ravgen, Inc. (Attachments: # 1 Exhibit 1)(Farnan, Brian) (Entered: 08/07/2023)
8/7/2023
  • Response
RESPONSE to 154 Objections, by Ravgen, Inc.. (Farnan, Brian) Modified on 8/8/2023 (nms). (Entered: 08/07/2023)
8/7/2023 NOTICE of Subpoenas by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Farnan, Brian) (Entered: 08/07/2023)
8/4/2023174
  • Order
ORAL ORDER Setting Teleconference: The Court has reviewed the Motion for Teleconference to Resolve Discovery Disputes (C.A. No. 20-1646, D.I. 241; C.A. No. 20-1730, D.I. 171; C.A. No. 20-1734, D.I. 170). A discovery dispute teleconference is scheduled for August 18, 2023 at 3:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than August 14, 2023, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than August 16, 2023, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. The letter shall address all outstanding discovery disputes. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 8/4/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 08/04/2023)
8/4/2023NOTICE to Take Deposition of Aditya Mohanty on 8/28/2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/04/2023)
8/4/2023NOTICE OF SERVICE of Responses and Objections to Plaintiff's First Notice of Deposition Pursuant to Rule 30(b)(6) filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 08/04/2023)
8/4/2023 NOTICE of Subpoena and Deposition of Frank J. Garofalo by Biora Therapeutics, Inc. (Joyce, Alexandra) (Entered: 08/04/2023)
8/4/2023
  • Motionby Δ
MOTION for Teleconference to Resolve Discovery Dispute - filed by Biora Therapeutics, Inc.. Motions referred to Jennifer L. Hall.(Joyce, Alexandra) (Entered: 08/04/2023)
8/3/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Responses to Biora Therapeutics, Inc.'s First Set of Individual Interrogatories (Nos. 1-4) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 08/03/2023)
7/31/2023OBJECTION to 151 Report and Recommendations, by Ravgen, Inc.. (Attachments: # 1 Certification)(Farnan, Brian) Modified on 8/1/2023 (nms). (Entered: 07/31/2023)
7/31/2023
  • Motion
MOTION to Set an Inequitable Conduct Trial - filed by Biora Therapeutics, Inc.. (Attachments: # 17.1.1 Certification, # 2 Proposed Order, # 3 Exhibits 1-31)Motions referred to Jennifer L. Hall.(Joyce, Alexandra) Modified on 8/1/2023 (nms). (Entered: 07/31/2023)
7/26/2023NOTICE OF SERVICE of Defendant Biora Therapeutics, Inc.'s Responses and Objections to Plaintiff Ravgen, Inc.'s First Set of Individual Interrogatories to Defendant Biora Therapeutics, Inc. (Nos. 1-3) filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 07/26/2023)
7/21/2023NOTICE OF SERVICE of Defendant's Second Amended Rule 26(a)(1) Disclosures filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 07/21/2023)
7/21/2023 NOTICE of Subpoena to Subhendra Mattagajasingh by Biora Therapeutics, Inc. (Silver, Daniel) (Entered: 07/21/2023)
7/21/2023 NOTICE of Subpoena to Alicia Hager by Biora Therapeutics, Inc. (Silver, Daniel) (Entered: 07/21/2023)
7/21/2023 NOTICE of Subpoena to Marian Damewood by Biora Therapeutics, Inc. (Silver, Daniel) (Entered: 07/21/2023)
7/21/2023 NOTICE of Subpoena to Wei-Chun Au by Biora Therapeutics, Inc. (Silver, Daniel) (Entered: 07/21/2023)
7/21/2023NOTICE to Take Deposition of Xin Guo on September 19, 2023 filed by Biora Therapeutics, Inc..(Silver, Daniel) (Entered: 07/21/2023)
7/21/2023NOTICE to Take Deposition of Ravinder Dhallan on August 14, 2023 filed by Biora Therapeutics, Inc..(Silver, Daniel) (Entered: 07/21/2023)
7/21/2023NOTICE to Take Deposition of John Varney on September 6, 2023 filed by Biora Therapeutics, Inc..(Silver, Daniel) (Entered: 07/21/2023)
7/20/2023
  • Order
SO ORDERED, re (148 in 1:20-cv-01730-RGA-JLH, 156 in 1:20-cv-01734-RGA-JLH, 219 in 1:20-cv-01646-RGA-JLH) Stipulation and Order to Extend Deadlines. Plaintiff to file objections to the Report and Recommendation on 7/31/2023 and Plaintiff to respond to Defendants' Objection on 8/7/2023. Ordered by Judge Jennifer L. Hall on 7/20/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 07/20/2023)
7/19/2023JOINT Interim Status Report, by Ravgen, Inc.. (Farnan, Brian) Modified on 7/19/2023 (nms). (Entered: 07/19/2023)
7/19/2023
  • Motion
STIPULATION Extending the deadlines for: (i) Plaintiff to file its objections to the Report and Recommendation and (ii) Plaintiff to respond to Defendants' Objection to (i) 7/31/2023 and (ii) 8/7/2023 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 07/19/2023)
7/19/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Supplemental Responses to Defendants' First Set of Common Interrogatories (Nos. 1-14) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 07/19/2023)
7/12/2023 OBJECTIONS to 151 Report and Recommendations, by Biora Therapeutics, Inc.. (Attachments: # 1 Certification, # 2 Exhibit A, # 3 Exhibit B)(Silver, Daniel) Modified on 7/12/2023 (nms). (Entered: 07/12/2023)
7/12/2023NOTICE OF SERVICE of Defendants' Second Set of Common Interrogatories to Plaintiff Ravgen, Inc. (Nos. 15-16) filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 07/12/2023)
7/12/2023
  • Order
SO ORDERED, re (140 in 1:20-cv-01730-RGA-JLH, 207 in 1:20-cv-01646-RGA-JLH, 152 in 1:20-cv-01734-RGA-JLH) Stipulation and Order to Extend Time to submit the Joint Interim Status Report to 7/19/2023. Ordered by Judge Jennifer L. Hall on 7/12/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 07/12/2023)
7/12/2023
  • Motion
STIPULATION Extending Deadline to submit the Joint Interim Status Report to 7/19/2023 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 07/12/2023)
7/10/2023
  • Motion for Claim Construction
REPORT AND RECOMMENDATION re Claim Construction Disputes. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 7/24/2023. Signed by Judge Jennifer L. Hall on 7/10/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 07/10/2023)
7/5/2023NOTICE to Take Deposition of Defendant on August 1, 2023 filed by Ravgen, Inc..(Farnan, Brian) (Entered: 07/05/2023)
7/3/2023NOTICE OF SERVICE of Defendant Biora Therapeutics, Inc.'s Responses and Objections to Plaintiff Ravgen, Inc.'s First Set of Common Interrogatories (Nos. 1-15) filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 07/03/2023)
6/28/2023NOTICE OF SERVICE of Plaintiff Ravgen Inc.'s Objections and Responses to Defendant Biora Therapeutics, Inc.'s Notice of Deposition to Ravgen, Inc. filed by Ravgen, Inc..(Farnan, Brian) (Entered: 06/28/2023)
6/27/2023NOTICE OF SERVICE of First Set of Individual Interrogatories to Plaintiff filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 06/27/2023)
6/21/2023
  • Motion for Claim Construction
CLAIM CONSTRUCTION ORDER CONSTRUING AGREED TERMS (see Order for further details). Signed by Judge Richard G. Andrews on 6/21/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(nms) (Entered: 06/21/2023)
6/21/2023 Letter to The Honorable Richard G. Andrews, from Brian E. Farnan, regarding proposed claim construction order. (Attachments: # 1 Exhibit 1)(Farnan, Brian) Modified on 6/21/2023 (nms). (Entered: 06/21/2023)
6/20/2023REDACTED VERSION of 142 Notice to Take Deposition by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 06/20/2023)
6/19/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Set of Individual Interrogatories to Defendant Biora Therapeutics, Inc. (Nos. 1-3) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 06/19/2023)
6/14/2023[SEALED] NOTICE to Take Deposition of Ravgen, Inc. on July 12, 2023 filed by Biora Therapeutics, Inc.. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 06/14/2023)
6/14/2023NOTICE OF SERVICE of Subpoena to Husch Blackwell LLP filed by Biora Therapeutics, Inc..(Silver, Daniel) (Entered: 06/14/2023)
6/14/2023NOTICE OF SERVICE of Subpoena to Michael J. Cronin filed by Biora Therapeutics, Inc..(Silver, Daniel) (Entered: 06/14/2023)
6/7/2023NOTICE OF SERVICE of Non-Party WellSpan York Hospital's Objections and Responses to Defendant Biora Therapeutics, Inc.'s Subpoena for Documents filed by WellSpan York Hospital.(Scrivani, Stacey) (Entered: 06/07/2023)
6/5/2023NOTICE OF SERVICE of Plaintiff Ravgen's First Responses To Defendants' First Set Of Common Interrogatories (Nos. 1-14) filed by Ravgen, Inc..(Farnan, Michael) (Entered: 06/05/2023)
6/2/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s First Set of Common Interrogatories to Defendants (Nos. 1-15) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 06/02/2023)
6/1/2023Minute Entry for proceedings held before Judge Jennifer L. Hall - Telephone Conference/Resumed Markman Hearing held on 6/1/2023. The Court issued its Report and Recommendation from the bench. The time to file any objections will begin once the Court has entered the written version on the docket. (*Court Reporter Deanna Warner.) Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 06/01/2023)
5/31/2023136
  • Order
ORAL ORDER Setting Teleconference: A teleconference is scheduled for June 1, 2023 at 4:00 PM before Judge Jennifer L. Hall, at which time the Court anticipates issuing its Report and Recommendation on the pending claim construction disputes. Counsel shall send dial-in information directly to the Court using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. Ordered by Judge Jennifer L. Hall on 5/31/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/31/2023)
5/31/2023Minute Entry for proceedings held before Judge Jennifer L. Hall - Markman Hearing held on 5/31/2023. (*Court Reporter Deanna Warner.) Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/31/2023)
5/30/2023
  • OrderGranted
ORDER granting Joint Motion for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices (C.A. 20-1646, D.I. 175; C.A. No. 20-1730, D.I. 122; C.A. No. 20-1734, D.I. 133). Signed by Judge Jennifer L. Hall on 5/30/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Main Document 135 replaced on 5/30/2023) (ceg). (Entered: 05/30/2023)
5/28/2023 Letter to The Honorable Jennifer L. Hall, from Jeremy A. Tigan, regarding agreed-upon construction of "Mutation" in advance of the Markman hearing. (Tigan, Jeremy) Modified on 5/30/2023 (nms). (Entered: 05/28/2023)
5/26/2023
  • Motionby Δ
MOTION for Exemption of Persons from the District of Delaware's May 15, 2023 Standing Order on Personal Devices - filed by Biora Therapeutics, Inc.. (Attachments: # 1 Proposed Order)Motions referred to Jennifer L. Hall.(Joyce, Alexandra) (Entered: 05/26/2023)
5/25/2023Remark: The Markman Hearing scheduled for May 31, 2023 at 10:00 AM before Judge Hall will be in courtroom 2B. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/25/2023)
5/24/2023 Letter to The Honorable Jennifer L. Hall, from Brian E. Farnan, regarding deposition limitations. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Farnan, Brian) Modified on 5/25/2023 (nms). (Entered: 05/24/2023)
5/19/2023
  • Order
SO ORDERED, re (172 in 1:20-cv-01646-RGA-JLH, 131 in 1:20-cv-01734-RGA-JLH, 120 in 1:20-cv-01730-RGA-JLH) Stipulation to Extend Time for the Joint Status Report on Deposition Limitations to 5/24/2023. Ordered by Judge Jennifer L. Hall on 5/19/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/19/2023)
5/19/2023
  • Motion to Extend Time
STIPULATION TO EXTEND TIME for the Joint Status Report on Deposition Limitations to 5/24/2023 - filed by Ravgen, Inc.. (Farnan, Michael) (Entered: 05/19/2023)
5/18/2023NOTICE OF SERVICE of Defendant's Amended Invalidity Contentions with Respect to U.S. Patent Nos. 7,332,277 and 7,727,720 filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 05/18/2023)
5/18/2023129
  • Motion for Claim Construction
ORAL ORDER: The Markman hearing scheduled for May 31, 2023 at 10:00 AM before Judge Hall will be conducted in-person in courtroom TBD. Each side shall be allocated 90 minutes for its presentation (i.e., the total allocation of time for the hearing will be 3 hours). Any slide presentations or demonstratives that the parties wish to use during the hearing shall be emailed to Cailah_Garfinkel@ded.uscourts.gov no later than 24 hours prior to the hearing. Ordered by Judge Jennifer L. Hall on 5/18/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/18/2023)
5/16/2023 NOTICE of Subsequent Authority Regarding Claim Construction by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Farnan, Brian) (Entered: 05/16/2023)
5/10/2023NOTICE OF SERVICE of Third Party Subpoena to Dr. Kimberly Heller filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 05/10/2023)
5/10/2023NOTICE OF SERVICE of Third Party Subpoena to Dr. Philip Bayliss filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 05/10/2023)
5/10/2023NOTICE OF SERVICE of Third Party Subpoena to Wellspan York Hospital filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 05/10/2023)
5/5/2023NOTICE OF SERVICE of Defendants' First Set of Common Interrogatories (Nos. 1-14) filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 05/05/2023)
5/5/2023 NOTICE of Subpoenas by Ravgen, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3)(Farnan, Brian) (Entered: 05/05/2023)
4/28/2023NOTICE OF SERVICE of Defendant Biora Therapeutics, Inc.'s Amended Initial Rule 26(a)(1) Disclosures filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 04/28/2023)
4/28/2023NOTICE OF SERVICE of Ravgen's Amended Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI") filed by Ravgen, Inc..(Farnan, Brian) (Entered: 04/28/2023)
4/27/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Defendant's Second Set of Requests for Production of Documents and Things (Nos. 73-92) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 04/27/2023)
4/25/2023Pro Hac Vice Attorney Frederick J. Ding, William B. Nichols, and Julianne M. Thomsen for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(mpb) (Entered: 04/25/2023)
4/24/2023
  • Order
SO ORDERED, re (163 in 1:20-cv-01646-RGA-JLH, 112 in 1:20-cv-01730-RGA-JLH, 119 in 1:20-cv-01734-RGA-JLH) Motion for Pro Hac Vice Appearance of Attorney Frederick J. Ding, Julianne M. Thomsen, and William B. Nichols filed by Ravgen, Inc.. Ordered by Judge Jennifer L. Hall on 4/24/2023. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 04/24/2023)
4/21/2023
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Frederick J. Ding, Julianne M. Thomsen, and William B. Nichols - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Michael) (Entered: 04/21/2023)
4/17/2023NOTICE OF SERVICE of Biora Therapeutics, Inc.'s Objections and Responses to Ravgen Inc.'s Second Set of Requests for Production of Documents and Things (Nos. 69-72) filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 04/17/2023)
4/17/2023REDACTED VERSION of 112 Appendix, Volume 4 of 4, by Ravgen, Inc.. (Attachments: # 1 Exhibit D27, # 2 Exhibit D28, # 3 Exhibit D29, # 4 Exhibit D30, # 5 Exhibit D31, # 6 Exhibit D32, # 7 Exhibit D33, # 8 Exhibit D34, # 9 Exhibit D35, # 10 Exhibit D36, # 11 Exhibit D37, # 12 Exhibit D38, # 13 Exhibit D39, # 14 Exhibit D40, # 15 Exhibit D41, # 16 Exhibit D42, # 17 Exhibit D43, # 18 Exhibit D44, # 19 Exhibit D45, # 20 Exhibit D46, # 21 Exhibit D47, # 22 Exhibit D48, # 23 Exhibit D49, # 24 Exhibit D50, # 25 Exhibit D51, # 26 Exhibit D52, # 27 Exhibit D53, # 28 Exhibit D54, # 29 Exhibit D55, # 30 Exhibit D56, # 31 Exhibit D57, # 32 Exhibit D58, # 33 Exhibit D59, # 34 Exhibit D60, # 35 Certificate of Service)(Farnan, Michael) Modified on 4/17/2023 (nms). (Entered: 04/17/2023)
4/13/2023
  • Answer
ANSWER to 104 Amended Answer to Complaint, Counterclaim by Ravgen, Inc..(Farnan, Brian) (Entered: 04/13/2023)
4/13/2023NOTICE OF SERVICE of Defendant's Amended Initial Disclosures Pursuant to Delaware Default Standard for Discovery, Paragraph 3 filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 04/13/2023)
4/12/2023 NOTICE of Lodging Defendants' Technology Tutorial with the Court by Myriad Genetics, Inc., Myriad Women's Health, Inc. (Tigan, Jeremy) (Entered: 04/12/2023)
4/10/2023 Letter to The Honorable Jennifer L. Hall, from Michael J. Farnan, regarding Markman hearing. (Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023)
4/10/2023[SEALED] APPENDIX, Volume 4 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit D27, # 2 Exhibit D28, # 3 Exhibit D29, # 4 Exhibit D30, # 5 Exhibit D31, # 6 Exhibit D32, # 7 Exhibit D33, # 8 Exhibit D34, # 9 Exhibit D35, # 10 Exhibit D36, # 11 Exhibit D37, # 12 Exhibit D38, # 13 Exhibit D39, # 14 Exhibit D40, # 15 Exhibit D41, # 16 Exhibit D42, # 17 Exhibit D43, # 18 Exhibit D44, # 19 Exhibit D45, # 20 Exhibit D46, # 21 Exhibit D47, # 22 Exhibit D48, # 23 Exhibit D49, # 24 Exhibit D50, # 25 Exhibit D51, # 26 Exhibit D52, # 27 Exhibit D53, # 28 Exhibit D54, # 29 Exhibit D55, # 30 Exhibit D56, # 31 Exhibit D57, # 32 Exhibit D58, # 33 Exhibit D59, # 34 Exhibit D60, # 35 Certificate of Service)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023)
4/10/2023 APPENDIX, Volume 3 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit D1, # 2 Exhibit D2, # 3 Exhibit D3, # 4 Exhibit D4, # 5 Exhibit D5, # 6 Exhibit D6, # 7 Exhibit D7, # 8 Exhibit D8, # 9 Exhibit D9, # 10 Exhibit D10, # 11 Exhibit D11, # 12 Exhibit D12, # 13 Exhibit D13, # 14 Exhibit D14, # 15 Exhibit D15, # 16 Exhibit D16, # 17 Exhibit D17, # 18 Exhibit D18, # 19 Exhibit D19, # 20 Exhibit D20, # 21 Exhibit D21, # 22 Exhibit D22, # 23 Exhibit D23, # 24 Exhibit D24, # 25 Exhibit D25, # 26 Exhibit D26)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023)
4/10/2023 APPENDIX, Volume 2 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit P30, # 2 Exhibit P31, # 3 Exhibit P32, # 4 Exhibit P33, # 5 Exhibit P34, # 6 Exhibit P35, # 7 Exhibit P36, # 8 Exhibit P37, # 9 Exhibit P38, # 10 Exhibit P39, # 11 Exhibit P40, # 12 Exhibit P41, # 13 Exhibit P42, # 14 Exhibit P43, # 15 Exhibit P44, # 16 Exhibit P45, # 17 Exhibit P46, # 18 Exhibit P47, # 19 Exhibit P48, # 20 Exhibit P49, # 21 Exhibit P50, # 22 Exhibit P51, # 23 Exhibit P52, # 24 Exhibit P53, # 25 Exhibit P54, # 26 Exhibit P55, # 27 Exhibit P56, # 28 Exhibit P57, # 29 Exhibit P58)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023)
4/10/2023 APPENDIX, Volume 1 of 4 to Joint Claim Construction Brief, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29)(Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023)
4/10/2023 JOINT Claim Construction Brief, filed by Ravgen, Inc.. (Farnan, Michael) Modified on 4/11/2023 (nms). (Entered: 04/10/2023)
4/10/2023NOTICE of filing the following Non-Paper material(s) in multi media format: Plaintiff's Technology Tutorial. Original Non-paper material(s) to be filed with the Clerk's Office. Notice filed by Brian E. Farnan on behalf of Ravgen, Inc. (Farnan, Brian) (Entered: 04/10/2023)
4/6/2023NOTICE OF SERVICE of Plaintiff Ravgen, Inc.'s Objections and Responses to Defendant's First Set of Requests for Production of Documents and Things (Nos. 1-72) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 04/06/2023)
4/4/2023NOTICE OF SERVICE of 1) Defendants' Sur-Reply Construction Brief; 2) Declaration of R. Noyes in Support of Defendants' Sur-Reply Claim Construction Brief; and 3) Declaration of Michael L. Metzker in Support of Defendants' Sur-Reply Claim Construction Brief filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Haynes, Christine) (Entered: 04/04/2023)
3/30/2023
  • Answer
AMENDED ANSWER to 1 Complaint and COUNTERCLAIMS against Ravgen, Inc., by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibits A-AA)(Joyce, Alexandra) Modified on 3/30/2023 (nms). (Entered: 03/30/2023)
3/29/2023103
  • Order
ORAL ORDER: IT IS HEREBY ORDERED that the transcript of the March 29, 2023 discovery dispute teleconference shall serve as the Order of the Court. Ordered by Judge Jennifer L. Hall on 3/29/2023. Associated Cases: 1:20-cv-01734-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH(ceg) (Entered: 03/29/2023)
3/29/2023Minute Entry for proceedings held before Judge Jennifer L. Hall - Discovery Dispute Teleconference held on 3/29/2023. (*Court Reporter Stacy Ingram, Hawkins Reporting Service.) Associated Cases: 1:20-cv-01734-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH(ceg) (Entered: 03/29/2023)
3/28/2023NOTICE OF SERVICE of Second Set of Requests for Production of Documents and Things (Nos. 73-92) filed by Biora Therapeutics, Inc..(Silver, Daniel) (Entered: 03/28/2023)
3/28/2023
  • Scheduling Order
AMENDED SCHEDULING ORDER: Claim Construction Surreply Brief due by 4/3/2023. Joint Claim Construction Brief and Technology Tutorials due by 4/10/2023. A Markman Hearing is set for 5/31/2023 at 10:00 AM before Judge Jennifer L. Hall. Interim Status Report due by 7/15/2023. Joinder of Parties due by 7/26/2023. Amended Pleadings due by 7/26/2023. Fact Discovery completed by 9/22/2023. Expert Discovery due by 2/16/2024. Case Dispositive Motions due by 4/4/2024. Answering Brief due 5/2/2024. Reply Brief due 5/16/2024. A Motion Hearing is set for 6/13/2024 at 01:00 PM before Judge Jennifer L. Hall. A Trial Sequencing Conference is set for 4/22/2024 at 01:00 PM before Judge Jennifer L. Hall. Proposed Pretrial Order due by 10/14/2024. A Pretrial Conference is set for 10/18/2024 at 09:00 AM in Courtroom 6A before Judge Richard G. Andrews. A 5-day Jury Trial is set for 10/28/2024 at 09:30 AM in Courtroom 6A before Judge Richard G. Andrews. (*See Order for details). Signed by Judge Jennifer L. Hall on 3/28/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 03/28/2023)
3/24/2023 PROPOSED Amended Scheduling Order, by Ravgen, Inc.. (Attachments: # 1 Letter)(Farnan, Michael) Modified on 3/24/2023 (nms). (Entered: 03/24/2023)
3/23/2023Pro Hac Vice Attorney Benjamin N. Luehrs and Kyle G. Petrie for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(mpb) (Entered: 03/23/2023)
3/23/2023REDACTED VERSION of 98 Letter, by Ravgen, Inc.. (Attachments: # 1 Exhibits A-C)(Farnan, Brian) Modified on 3/23/2023 (nms). (Entered: 03/23/2023)
3/22/2023[SEALED] Letter to The Honorable Jennifer L. Hall, from Brian E. Farnan, regarding response to Defendants' March 16, 2023 letter. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Farnan, Brian) Modified on 3/22/2023 (nms). (Entered: 03/22/2023)
3/17/2023NOTICE OF SERVICE of Plaintiff's Second Set of Requests for the Production of Documents and Things (Nos. 69-72) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 03/17/2023)
3/16/2023 Letter to The Honorable Jennifer L. Hall, from Defendants, regarding request for leave to amend answers and counterclaims. (Attachments: # 1 Exhibits 1 -11, # 2 Illumina's Proposed Order, # 3 Roche's Proposed Order, # 4 FMI's Proposed Order, # 5 Biora's Proposed Order)(Joyce, Alexandra) Modified on 3/16/2023 (nms). (Entered: 03/16/2023)
3/10/202395
  • Order
ORAL ORDER Setting Teleconference: The Court has reviewed the Joint Motion for Teleconference to Resolve Discovery Disputes (D.I. 94 ). A discovery dispute teleconference is scheduled for March 29, 2023 at 3:00 PM Eastern Time before Judge Jennifer L. Hall. By no later than March 16, 2023, the party(ies) seeking relief shall file with the Court a letter, not to exceed three pages, in no less than 12-point font, outlining the issues in dispute and its position on those issues. By no later than March 22, 2023, any party(ies) opposing the application for relief may file a letter, not to exceed three pages, in no less than 12-point font, outlining that party's reasons for its opposition. Counsel is reminded to provide courtesy copies. Counsel shall send dial-in information directly to the Court, no later than 24 hours prior to the hearing, using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. The Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. Ordered by Judge Jennifer L. Hall on 3/10/2023. (ceg) (Entered: 03/10/2023)
3/10/2023Minute Entry for proceedings held before Judge Jennifer L. Hall - Telephonic Scheduling Conference held on 3/10/2023. Parties to file revised proposed scheduling order on or before 3/24/2023. (*Court Reporter Deanna Warner.) Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 03/10/2023)
3/8/2023
  • Motion
Joint Motion for Teleconference to Resolve Disputes - filed by Biora Therapeutics, Inc.. Motions referred to Jennifer L. Hall.(Joyce, Alexandra) Modified on 3/8/2023 (nms). (Entered: 03/08/2023)
3/8/2023
  • Order
SO ORDERED, re (86 in 1:20-cv-01644-RGA-JLH, 128 in 1:20-cv-01646-RGA-JLH, 89 in 1:20-cv-01730-RGA-JLH, 93 in 1:20-cv-01734-RGA-JLH) Motion for Pro Hac Vice Appearance of Attorney Benjamin N. Luehrs and Kyle G. Petrie. Ordered by Judge Jennifer L. Hall on 3/8/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 03/08/2023)
3/8/2023
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Benjamin N. Luehrs and Kyle G. Petrie - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Michael) (Entered: 03/08/2023)
3/7/202392
  • Motion to Amend Answer
ORAL ORDER: Biora Therapeutics, Inc.'s Motion for Leave to Amend its Answer and Counterclaims (D.I. 87 ) and Opening Brief in Support (D.I. 88 ) are STRICKEN. The Court has not reviewed their contents. Any motion for leave to amend a pleading must be made pursuant to Paragraphs 8(g) and 9 of the Court's May 19, 2021 Order (D.I. 21 ). Ordered by Judge Jennifer L. Hall on 3/7/2023. (ceg) (Entered: 03/07/2023)
3/7/202391
  • Order
ORAL ORDER Setting Telephonic Scheduling Conference: A Scheduling Conference is scheduled for March 10, 2023 at 10:00 AM before Judge Jennifer L. Hall. The parties shall call the Court's conference line at (877) 336-1829, access code: 7090640. Ordered by Judge Jennifer L. Hall on 3/7/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 03/07/2023)
3/7/2023NOTICE OF SERVICE of Defendant's First Set of Requests for Production of Documents and Things (Nos. 1-72) Directed to Plaintiff filed by Biora Therapeutics, Inc..(Joyce, Alexandra) (Entered: 03/07/2023)
3/7/2023 Letter to The Honorable Jennifer L. Hall, from Michael J. Farnan, regarding request for guidance as to whether to follow discovery dispute procedures or brief Motion to Amend. (Farnan, Michael) Modified on 3/8/2023 (nms). (Entered: 03/07/2023)
3/6/2023 OPENING BRIEF in Support re 87 MOTION for Leave to Amend Answer and Counterclaims, filed by Biora Therapeutics, Inc..Answering Brief/Response due date per Local Rules is 3/20/2023. (Joyce, Alexandra) Modified on 3/7/2023 (nms). (Entered: 03/06/2023)
3/6/2023
  • Motion to Amend Answerby Δ
MOTION for Leave to Amend Answer and Counterclaims - filed by Biora Therapeutics, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Proposed Order, # 4 7.1.1 Certification)Motions referred to Jennifer L. Hall.(Joyce, Alexandra) (Entered: 03/06/2023)
3/6/2023 PROPOSED Amended Scheduling Order by Ravgen, Inc. (Attachments: # 1 Letter to The Honorable Jennifer L. Hall)(Farnan, Michael) Modified docket text on 3/6/2023 (ceg). (Entered: 03/06/2023)
3/1/2023
  • Motion to Appear Pro Hac Vice
SO ORDERED, 85 Motion for Pro Hac Vice Appearance of Attorney Harry Hanson and Alix Pisani filed by Biora Therapeutics, Inc. Ordered by Judge Jennifer L. Hall on 3/1/2023. (ceg) (Entered: 03/01/2023)
3/1/2023
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Harry Hanson and Alix Pisani - filed by Biora Therapeutics, Inc.. Motions referred to Jennifer L. Hall.(Joyce, Alexandra) (Entered: 03/01/2023)
2/28/2023
  • Order
SO ORDERED, re (83 in 1:20-cv-01644-RGA-JLH, 84 in 1:20-cv-01734-RGA-JLH, 125 in 1:20-cv-01646-RGA-JLH, 85 in 1:20-cv-01730-RGA-JLH) Stipulation to Extend Time to Submit a Proposed Scheduling Order to 3/6/2023. Ordered by Judge Jennifer L. Hall on 2/28/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 02/28/2023)
2/27/2023
  • Motion
STIPULATION Extending Deadline to Submit a Scheduling Order to 3/6/2023 - filed by Ravgen, Inc.. (Farnan, Michael) Modified on 2/28/2023 (nms). (Entered: 02/27/2023)
2/22/2023Amended Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Biora Therapeutics, Inc.. (Joyce, Alexandra) (Entered: 02/22/2023)
2/17/2023NOTICE requesting Clerk to remove Ian R. Liston and Jennifer A. Ward as co-counsel. Reason for request: Substitution of Counsel Has Entered Appearance. (Liston, Ian) (Entered: 02/17/2023)
2/17/2023NOTICE of Appearance by Alexandra M. Joyce on behalf of Biora Therapeutics, Inc. (Joyce, Alexandra) (Entered: 02/17/2023)
2/17/2023NOTICE of Appearance by Daniel M. Silver on behalf of Biora Therapeutics, Inc. (Silver, Daniel) (Entered: 02/17/2023)
2/13/202379
  • Motion to Lift StayGranted
ORAL ORDER: The request to lift the stay (D.I. 79 ) is GRANTED. The parties shall meet and confer and submit a proposed scheduling order on or before February 27, 2023. ORDERED by Judge Jennifer L. Hall on 2/13/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 02/13/2023)
2/8/2023
  • Order
SO ORDERED, 76 Stipulation and Order to Amend Party Name and Case Caption. Signed by Judge Jennifer L. Hall on 2/8/2023. (ceg) (Entered: 02/08/2023)
2/6/2023JOINT Status Report, by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Farnan, Brian) Modified on 2/7/2023 (nms). (Entered: 02/06/2023)
2/3/2023 STIPULATION To Amend Party Name and Case Caption by Progenity, Inc.. (Attachments: # 1 Exhibit A)(Liston, Ian) (Entered: 02/03/2023)
2/3/2023 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Progenity, Inc.. (Liston, Ian) (Entered: 02/03/2023)
2/3/2023CORRECTING ENTRY: The Notice of Name Change filed at D.I. 75 has been removed from that docket after a call between the filer and chambers. Counsel will refile a stipulation regarding the modification of defendant's name. (nms) (Entered: 02/03/2023)
2/2/2023DEFICIENCY NOTICE issued by the Court to Defendant: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (nms) (Entered: 02/02/2023)
2/2/2023
  • Order
SO ORDERED, re (78 in 1:20-cv-01644-RGA-JLH, 74 in 1:20-cv-01734-RGA-JLH, 82 in 1:20-cv-01730-RGA-JLH, 120 in 1:20-cv-01646-RGA-JLH) Stipulation to Extend Time for the submission of a status report on the recent inter partes review decisions to February 6, 2023. ORDERED by Judge Jennifer L. Hall on 2/2/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 02/02/2023)
2/1/2023
  • Motion
STIPULATION Extending Deadline to Submit Status Report to February 6, 2023 - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Cottrell, Frederick) Modified on 2/2/2023 (nms). (Entered: 02/01/2023)
2/1/2023NOTICE requesting Clerk to remove Tina Hanson and Tung-On Kong as co-counsel. Reason for request: Substitute counsel have been admitted Pro Hac Vice. (Liston, Ian) (Entered: 02/01/2023)
1/31/2023Pro Hac Vice Attorney Amanda L. Major and Michael J. Summersgill for Progenity, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 01/31/2023)
1/31/2023
  • Motion to Appear Pro Hac Vice
SO ORDERED, 72 Motion for Pro Hac Vice Appearance of Attorney Amanda L. Major and Michael Summergill filed by Progenity, Inc. ORDERED by Judge Jennifer L. Hall on 1/31/2023. (ceg) (Entered: 01/31/2023)
1/31/2023
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Amanda L. Major and Michael Summergill - filed by Progenity, Inc.. Motions referred to Jennifer L. Hall.(Liston, Ian) (Entered: 01/31/2023)
1/9/202371
  • Order
ORAL ORDER: The parties shall file an updated status report on February 2, 2023. ORDERED by Judge Jennifer L. Hall on 1/9/2023. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 01/09/2023)
1/4/2023Joint Status Report, by Ravgen, Inc.. (Farnan, Brian) Modified on 1/4/2023 (nms). (Entered: 01/04/2023)
12/27/2022
  • Order
SO ORDERED, re (79 in 1:20-cv-01730-RGA-JLH, 117 in 1:20-cv-01646-RGA-JLH, 69 in 1:20-cv-01734-RGA-JLH, 75 in 1:20-cv-01644-RGA-JLH) Stipulation to Extend Time for the submission of a status report on the recent inter partes review decision to 1/5/2023. ORDERED by Judge Jennifer L. Hall on 12/27/2022. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 12/27/2022)
12/21/2022 STIPULATION to Extend Time to submit status report - filed by Ravgen, Inc.. (Farnan, Michael) Modified on 12/21/2022 (nms). (Entered: 12/21/2022)
11/11/2022JOINT Status Report, by Ravgen, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Farnan, Brian) Modified on 11/14/2022 (nms). (Entered: 11/11/2022)
11/9/2022SO ORDERED, re Stipulation and Order to Extend Time for the parties to file a joint status report to November 11, 2022. (73 in 1:20-cv-01644-RGA-JLH, 115 in 1:20-cv-01646-RGA-JLH, 77 in 1:20-cv-01730-RGA-JLH, 67 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/9/2022. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 11/09/2022)
11/8/2022 STIPULATION TO EXTEND TIME for the parties to file a joint status report to November 11, 2022 - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc., Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc., Illumina, Inc., Verinata Health, Inc., Progenity, Inc.. (Tigan, Jeremy) (Entered: 11/08/2022)
4/4/2022CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). (Taylor, Daniel) (Entered: 04/04/2022)
3/14/2022
  • Order
SO ORDERED, 63 Stipulation Regarding Limited IPR Estoppel Applicable to Non-Petitioner Defendants Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc., Roche Molecular Systems, Inc., Foundation Medicine, Inc. and Progenity, Inc. Signed by Judge Jennifer L. Hall on 3/14/2022. (ceg) (Entered: 03/14/2022)
3/10/2022 Letter to The Honorable Jennifer L. Hall, from Frederick L. Cottrell, III, regarding stipulations for limited IPR estoppel. (Cottrell, Frederick) Modified on 3/10/2022 (nms). (Entered: 03/10/2022)
3/9/2022 Letter to The Honorable Jennifer L. Hall, from Michael J. Farnan, regarding stipulations for limited IPR estoppel. (Farnan, Michael) Modified on 3/9/2022 (nms). (Entered: 03/09/2022)
3/8/2022 STIPULATION Regarding Limited IPR Estoppel Applicable to Non-Petitioner Defendants Ariosa Diagnostics, Inc., Roche Sequencing Solutions, Inc., Roche Molecular Systems, Inc., Foundation Medicine, Inc. and Progenity, Inc., by Progenity, Inc.. (Liston, Ian) Modified on 3/9/2022 (nms). (Entered: 03/08/2022)
3/1/202262
  • Motion to Stay
ORAL ORDER: For the reasons announced from the bench at the March 1, 2022 hearing, Defendants' Motions to Stay (C.A. No. 20-1730, D.I. 52; C.A. No. 20-1644, D.I. 59; C.A. No. 20-1646, D.I. 100; C.A. No. 20-1734, D.I. 54) are GRANTED subject to non-petitioner Defendants filing within 7 days a stipulation of estoppel consistent with the hearing today. Within 7 days of any final written decision from the PTAB in any related IPR, the parties shall submit a joint status report to the Court indicating whether they wish to extend the stay. If the parties are not in agreement, the joint status report should include at least an updated chart of challenged claims and IPR decisions similar to the chart in the previous joint letter (C.A. No. 20-1730, D.I. 72) and should set forth the parties' positions. ORDERED by Judge Jennifer L. Hall on 3/1/2022. Associated Cases: 1:20-cv-01730-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 03/01/2022)
3/1/2022Minute Entry for proceedings held before Judge Jennifer L. Hall - Motion Hearing held on 3/1/2022 via video conference re Defendant Myriad's Motion to Stay (C.A. No. 20-1730, D.I. 52), and the Notices of Joinder filed by Defendants Ilumina (C.A. No. 20-1644, D.I. 59), Roche, FMI (C.A. No. 1646, D.I. 100), and Progenity (C.A. No. 20-1734, D.I. 54) (*Court Reporter Jennifer Guy.) Associated Cases: 1:20-cv-01730-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 03/01/2022)
2/28/2022NOTICE to Take Deposition of Brian G. Van Ness, Ph.D. on March 1, 2022 filed by Myriad Genetics, Inc., Myriad Women's Health, Inc..(Tigan, Jeremy) (Entered: 02/28/2022)
2/28/2022 Letter to The Honorable Jennifer L. Hall, from Frederick L. Cottrell, III, regarding response to the Court's Oral Order of February 24, 2022. (Cottrell, Frederick) Modified on 2/28/2022 (ceg). Modified on 2/28/2022 (nms). (Entered: 02/28/2022)
2/24/2022REDACTED VERSION of 58 Declaration, by Ravgen, Inc.. (Attachments: # 1 Exhibits 1-10, # 2 Certificate of Service)(Farnan, Brian) Modified on 2/24/2022 (nms). (Entered: 02/24/2022)
2/24/2022[SEALED] DECLARATION of Jamie L. Kringstein re 57 Opposition, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Certificate of Service)(Farnan, Brian) Modified on 2/24/2022 (nms). (Entered: 02/24/2022)
2/24/2022OPPOSITION to 54 Joinder, by Ravgen, Inc.. (Farnan, Brian) Modified on 2/24/2022 (nms). (Entered: 02/24/2022)
2/24/202256
  • Order
ORAL ORDER Setting Hearing on Motions: Having reviewed Defendant Myriad's Motion to Stay (C.A. No. 20-1730, D.I. 52), and the briefing filed in support thereof and in opposition thereto, and having reviewed the Notices of Joinder filed by Defendants Ilumina (C.A. No. 20-1644, D.I. 59), Roche, FMI (C.A. No. 1646, D.I. 100), and Progenity (C.A. No. 20-1734, D.I. 54) it is HEREBY ORDERED that a brief hearing on the motions is scheduled for March 1, 2022 at 9:00 AM via video conference before Judge Jennifer L. Hall. On or before noon on February 28, 2022, the parties shall send a joint email to Cailah_Garfinkel@ded.uscourts.gov containing the following information: (1) a video conference link with instructions on how to join the conference; (2) a separate audio-only dial-in; and (3) a list of attendees for each party, specifying who will be speaking on behalf of each party. Any video conference must be sufficient to accommodate Judge Hall, the courtroom deputy, a law clerk, and the court reporter. Also, on or before noon on February 28, 2022, the parties shall meet and confer and file a joint letter setting forth the following: (A) a chart that will enable the Court to easily identify which claims are asserted against each party in these litigations, which claims are at issue in the reexamination(s), which claims are at issue in the instituted IPRs and the IPRs for which an institution decision is still pending, and which claims are at issue in this litigation but are not otherwise being challenged at the PTO; and (B) whether the parties can agree on the scope of estoppel that should apply to the non-petitioner defendants if a stay is granted and, if not, the parties' respective positions on any estoppel that should be required as a condition of any stay entered by the Court. ORDERED by Judge Jennifer L. Hall on 2/24/2022. Associated Cases: 1:20-cv-01730-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 02/24/2022)
2/14/2022
  • Motion to Extend Time
SO ORDERED, 55 Stipulation to Extend Time to Complete Document Production for Requests Served by November 5, 2021 to March 15, 2022. ORDERED by Judge Jennifer L. Hall on 2/14/2022. (ceg) (Entered: 02/14/2022)
2/11/2022
  • Motion to Extend Timeby Δ
STIPULATION TO EXTEND TIME Complete Document Production for Requests Served by November 5, 2021 to March 15, 2022 - filed by Progenity, Inc.. (Liston, Ian) (Entered: 02/11/2022)
2/11/2022JOINDER in Motion to Stay, by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Attachments: # 1 7.1.1 Certification, # 2 Proposed Order)(Delcollo, Renee) Modified on 2/14/2022 (nms). Modified on 3/1/2022 (ceg). (Entered: 02/11/2022)
1/21/2022NOTICE OF SERVICE of (1) Defendants' Answering Claim Construction Brief, (2) Declaration of Omar A. Khan in Support of Defendants' Answering Claim Construction Brief, and (3) Declaration of Dr. Michael L. Metzker in Support of Answering Claim Construction Brief filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc..(Delcollo, Renee) (Entered: 01/21/2022)
12/29/2021
  • Motion to Extend Time
SO ORDERED, re Stipulation and Order to Extend Time (96 in 1:20-cv-01646-RGA-JLH, 52 in 1:20-cv-01734-RGA-JLH, 56 in 1:20-cv-01644-RGA-JLH, 59 in 1:20-cv-01730-RGA-JLH). *Reset Deadlines for Claim Construction Briefing: Claim Construction Answering Brief due by 1/21/2022; Claim Construction Reply Brief due by 2/11/2022; Claim Construction Surreply Brief due by 3/4/2022; Joint Claim Construction Brief; Tutorial on the technology due by 3/9/2022. ORDERED by Judge Jennifer L. Hall on 12/29/2021. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01644-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 12/29/2021)
12/21/2021 STIPULATION and Proposed Order to Extend Time - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) Modified on 12/23/2021 (nms). (Entered: 12/21/2021)
12/16/2021NOTICE OF SERVICE of Defendant Progenity, Inc.'s Objections and Responses to Ravgen, Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-68) filed by Progenity, Inc..(Liston, Ian) (Entered: 12/16/2021)
12/10/2021
  • Order
SO ORDERED, re Stipulated Protective Order. (88 in 1:20-cv-01646-RGA-JLH, 49 in 1:20-cv-01734-RGA-JLH, 50 in 1:20-cv-01644-RGA-JLH, 54 in 1:20-cv-01730-RGA-JLH). Signed by Judge Jennifer L. Hall on 12/10/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 12/10/2021)
12/8/2021 PROPOSED Stipulated Protective Order by Ravgen, Inc. (Farnan, Brian) Modified on 12/8/2021 (ceg). (Entered: 12/08/2021)
11/29/2021SO ORDERED, re Stipulation to Extend Time to submit the proposed Protective Order to 12/8/2021. (87 in 1:20-cv-01646-RGA-JLH, 49 in 1:20-cv-01644-RGA-JLH, 48 in 1:20-cv-01734-RGA-JLH, 51 in 1:20-cv-01730-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/29/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 11/29/2021)
11/23/2021 STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 12/8/2021 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 11/23/2021)
11/12/2021JOINT Claim Construction Chart, Part 3 of 3, by Ravgen, Inc.. (Attachments: # 1 Exhibit 29, # 2 Exhibit 30, # 3 Exhibit 31, # 4 Exhibit 32, # 5 Exhibit 33, # 6 Exhibit 34, # 7 Exhibit 35, # 8 Exhibit 36, # 9 Exhibit 37, # 10 Exhibit 38, # 11 Exhibit 39, # 12 Exhibit 40, # 13 Exhibit 41)(Farnan, Brian) Modified on 11/15/2021 (nms). (Entered: 11/12/2021)
11/12/2021JOINT Claim Construction Chart, Part 2 of 2, by Ravgen, Inc.. (Attachments: # 1 Exhibit 15, # 2 Exhibit 16, # 3 Exhibit 17, # 4 Exhibit 18, # 5 Exhibit 19, # 6 Exhibit 20, # 7 Exhibit 21, # 8 Exhibit 22, # 9 Exhibit 23, # 10 Exhibit 24, # 11 Exhibit 25, # 12 Exhibit 26, # 13 Exhibit 27, # 14 Exhibit 28)(Farnan, Brian) Modified on 11/15/2021 (nms). (Entered: 11/12/2021)
11/12/2021JOINT Claim Construction Chart, Part 1 of 3, by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14)(Farnan, Brian) Modified on 11/15/2021 (nms). (Entered: 11/12/2021)
11/10/2021
  • Order
SO ORDERED, re Parties' proposals regarding the claim construction briefing structure and limitations. (See Letter at 47 in 1:20-cv-01730-RGA-JLH, 79 in 1:20-cv-01646-RGA-JLH, 44 in 1:20-cv-01734-RGA-JLH, 44 in 1:20-cv-01644-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/10/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 11/10/2021)
11/10/2021SO ORDERED, re Stipulation to Extend Time to file a joint claim construction chart to November 12, 2021. (43 in 1:20-cv-01734-RGA-JLH, 46 in 1:20-cv-01730-RGA-JLH, 43 in 1:20-cv-01644-RGA-JLH, 77 in 1:20-cv-01646-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 11/10/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 11/10/2021)
11/5/2021 Letter to The Honorable Jennifer L. Hall from Brian E. Farnan regarding Proposal for Claim Construction Briefs. (Farnan, Brian) (Entered: 11/05/2021)
11/5/2021 STIPULATION TO EXTEND TIME to file a joint claim construction chart to November 12, 2021 - filed by Myriad Genetics, Inc., Myriad Women's Health, Inc.. (Tigan, Jeremy) (Entered: 11/05/2021)
11/3/2021Pro Hac Vice Attorney Nicholas Halkowski for Progenity, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) (Entered: 11/03/2021)
11/2/2021NOTICE OF SERVICE of Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-68) filed by Ravgen, Inc..(Farnan, Brian) (Entered: 11/02/2021)
10/29/2021NOTICE OF SERVICE of Defendant's Identification of Proposed Constructions filed by Progenity, Inc..(Liston, Ian) (Entered: 10/29/2021)
10/29/2021NOTICE OF SERVICE of Ravgen's Proposed Claim Constructions filed by Ravgen, Inc..(Farnan, Brian) (Entered: 10/29/2021)
10/25/202139SO ORDERED, re 37 STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 11/24/2021, 38 STIPULATION TO EXTEND TIME for the parties' deadline to exchange proposed claim constructions to October 29, 2021. ORDERED by Judge Jennifer L. Hall on 10/25/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH. (cna, ) (Entered: 10/25/2021)
10/22/2021
  • Motion to Extend Time
STIPULATION TO EXTEND TIME for the parties' deadline to exchange proposed claim constructions to October 29, 2021 - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) (Entered: 10/22/2021)
10/22/2021 STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 11/24/2021 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 10/22/2021)
10/4/2021
  • Motion to Appear Pro Hac Vice
SO ORDERED, 36 Motion for Pro Hac Vice Appearance of Attorney Nicholas Halkowski filed by Progenity, Inc. ORDERED by Judge Jennifer L. Hall on 10/4/2021. (ceg) (Entered: 10/04/2021)
10/4/2021
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Nicholas Halkowski - filed by Progenity, Inc.. (Attachments: # 1 Certification of Nicholas Halkowski)Motions referred to Jennifer L. Hall.(Liston, Ian) (Entered: 10/04/2021)
10/4/2021NOTICE OF SERVICE of Progenity's Identification of Claim Terms for Construction filed by Progenity, Inc..(Liston, Ian) (Entered: 10/04/2021)
10/1/2021NOTICE OF SERVICE of Ravgen's Identification of Claim Terms for Construction filed by Ravgen, Inc..(Farnan, Brian) (Entered: 10/01/2021)
9/27/2021SO ORDERED, re Stipulation to Extend Time to submit a Proposed Protective Order to 10/25/2021. (67 in 1:20-cv-01646-RGA-JLH, 34 in 1:20-cv-01644-RGA-JLH, 36 in 1:20-cv-01730-RGA-JLH, 33 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 9/27/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 09/27/2021)
9/24/2021 STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to 10/25/2021 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 09/24/2021)
9/17/2021NOTICE OF SERVICE of Initial Invalidity Contentions filed by Progenity, Inc..(Liston, Ian) (Entered: 09/17/2021)
8/31/2021
  • Motion to Extend Time
SO ORDERED, re Stipulation to Extend Time on Certain Scheduling Order Deadlines. (34 in 1:20-cv-01730-RGA-JLH, 65 in 1:20-cv-01646-RGA-JLH, 32 in 1:20-cv-01644-RGA-JLH, 31 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 8/31/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) Modified on 8/31/2021 (ceg). (Entered: 08/31/2021)
8/30/2021SO ORDERED, re Stipulation to Extend Time for the submission of the Proposed Protective Order to 9/24/2021. (30 in 1:20-cv-01734-RGA-JLH, 33 in 1:20-cv-01730-RGA-JLH, 64 in 1:20-cv-01646-RGA-JLH, 31 in 1:20-cv-01644-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 8/30/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 08/30/2021)
8/27/2021
  • Motion to Extend Time
STIPULATION to Extend Time on Certain Scheduling Order Deadlines - filed by Ariosa Diagnostics, Inc., Foundation Medicine, Inc., Roche Molecular System, Inc., Roche Sequencing Solutions, Inc.. (Delcollo, Renee) Modified docket text on 8/31/2021 (ceg). (Entered: 08/27/2021)
8/26/2021 STIPULATION TO EXTEND TIME for the submission of the proposed Protective Order to 9/24/2021 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 08/26/2021)
7/30/2021NOTICE OF SERVICE of Ravgen's Initial Infringement Contentions filed by Ravgen, Inc..(Farnan, Brian) (Entered: 07/30/2021)
7/29/2021SO ORDERED, re Stipulation to Extend Time for the submission of the Proposed Protective Order to 8/27/2021. (31 in 1:20-cv-01730-RGA-JLH, 29 in 1:20-cv-01644-RGA-JLH, 56 in 1:20-cv-01646-RGA-JLH, 28 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 7/29/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 07/29/2021)
7/28/2021 STIPULATION TO EXTEND TIME for the submission of the proposed Protective Order to 8/27/2021 - filed by Ravgen, Inc.. (Farnan, Michael) (Entered: 07/28/2021)
7/15/2021
  • Order
SO ORDERED, re Stipulation Amending Scheduling Order. (27 in 1:20-cv-01734-RGA-JLH, 52 in 1:20-cv-01646-RGA-JLH, 29 in 1:20-cv-01730-RGA-JLH, 28 in 1:20-cv-01644-RGA-JLH).. ORDERED by Judge Jennifer L. Hall on 7/15/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 07/15/2021)
7/15/2021SO ORDERED, re Stipulation to Extend Time to Submit the Proposed Protective Order to 7/30/2021. (51 in 1:20-cv-01646-RGA-JLH, 27 in 1:20-cv-01644-RGA-JLH, 26 in 1:20-cv-01734-RGA-JLH, 28 in 1:20-cv-01730-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 7/15/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 07/15/2021)
7/13/2021 STIPULATION Amending Scheduling Order by Ravgen, Inc.. (Farnan, Brian) (Entered: 07/13/2021)
7/13/2021 STIPULATION TO EXTEND TIME to submit the proposed Protective Order to 7/30/2021 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 07/13/2021)
6/30/2021SO ORDERED, Stipulation to Extend Time to submit a Proposed Protective Order to 7/16/2021. (49 in 1:20-cv-01646-RGA-JLH, 27 in 1:20-cv-01730-RGA-JLH, 26 in 1:20-cv-01644-RGA-JLH, 25 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 6/30/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 06/30/2021)
6/30/2021 STIPULATION TO EXTEND TIME to submit a Proposed Protective Order to 7/16/2021 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 06/30/2021)
6/21/2021SO ORDERED, Stipulation to Extend Time for the submission of the proposed Protective Order to 7/2/2021. (25 in 1:20-cv-01644-RGA-JLH, 26 in 1:20-cv-01730-RGA-JLH, 48 in 1:20-cv-01646-RGA-JLH, 24 in 1:20-cv-01734-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 6/21/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 06/21/2021)
6/16/2021
  • Order
ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (daniel_taylor@ded.uscourts.gov), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 6/16/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(Taylor, Daniel) (Entered: 06/16/2021)
6/16/2021 STIPULATION TO EXTEND TIME for the submission of the proposed Protective Order to 7/2/2021 - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 06/16/2021)
6/4/2021NOTICE OF SERVICE of Defendant Progenity, Inc.'s Core Technical Document Production Pursuant to Paragraph 7(b) of the Joint Scheduling Order re 21 Scheduling Order,,,, filed by Progenity, Inc..(Liston, Ian) (Entered: 06/04/2021)
6/1/2021Pro Hac Vice Attorney Peter Zhu, Jun Tong, Joze Welsh for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH (myr) (Entered: 06/01/2021)
5/25/2021
  • Motion to Appear Pro Hac Vice
SO ORDERED, Motion for Pro Hac Vice Appearance of Attorney Peter Zhu, Jun Tong, and Joze Welsh filed by Ravgen, Inc. (24 in 1:20-cv-01730-RGA-JLH, 22 in 1:20-cv-01734-RGA-JLH, 24 in 1:20-cv-01644-RGA-JLH, 45 in 1:20-cv-01646-RGA-JLH). ORDERED by Judge Jennifer L. Hall on 5/25/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/25/2021)
5/25/2021
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney Peter Zhu, Jun Tong, and Joze Welsh - filed by Ravgen, Inc.. Motions referred to Jennifer L. Hall.(Farnan, Brian) (Entered: 05/25/2021)
5/19/2021CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(Taylor, Daniel) (Entered: 05/19/2021)
5/19/2021
  • Scheduling Order
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties and Amendment of Pleadings due by 7/26/2022. Fact Discovery completed by 8/16/2022. Opening Expert Reports due by 10/3/2022. Rebuttal Expert Reports due by 11/17/2022. Expert Discovery due by 2/9/2023. Interim Status Report due by 3/15/2022. Dispositive Motions due by 3/9/2023. Answering Brief due 4/6/2023. Reply Brief due 4/20/2023. A Motion Hearing is set for 5/5/2023 at 01:00 PM before Judge Jennifer L. Hall. Joint Claim Construction Brief due by 3/3/2022. A Markman Hearing is set for 4/12/2022 at 01:00 PM before Judge Jennifer L. Hall. A Trial Ordering and Scheduling Conference is set for 3/2/2023 at 01:00 PM before Judge Jennifer L. Hall. Proposed Final Pretrial Order due by 8/21/2023. A Pretrial Conference is set for 8/25/2023 at 09:00 AM before Judge Richard G. Andrews. A 5 day Jury Trial is set for 9/11/2023 at 09:30 AM in Courtroom 6A before Judge Richard G. Andrews. (*See Order for complete details). Signed by Judge Jennifer L. Hall on 5/19/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/19/2021)
5/12/2021CORRECTING ENTRY: The cover letter attached to the revised scheduling order has been replaced per the filing party's request. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 05/12/2021)
5/11/2021 PROPOSED Scheduling Order, by Ravgen, Inc.. (Attachments: # 1 Letter)(Farnan, Brian) (Attachment 1 replaced on 5/12/2021) (ceg). (Entered: 05/11/2021)
5/3/2021NOTICE requesting Clerk to remove Michael Ling as co-counsel.. (Farnan, Brian) (Entered: 05/03/2021)
4/30/2021NOTICE OF SERVICE of (1) Defendant Progenity, Inc.'s Initial Rule 26(A)(1) Disclosures and (2) Defendant Progenity, Inc.'s Initial Disclosures Pursuant to the Delaware Default Standard for Discovery, Paragraph 3 filed by Progenity, Inc..(Ward, Jennifer) (Entered: 04/30/2021)
4/30/2021NOTICE OF SERVICE of (i) Plaintiff's Initial Disclosures Pursuant to Fed. R. Civ. P. 26; (ii) Ravgen's Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery, Including Discovery of Electronically Stored Information ("ESI"); and (iii) Ravgen's Preliminary Identification of Asserted Patents and Accused Products filed by Ravgen, Inc..(Farnan, Brian) (Entered: 04/30/2021)
4/27/202116
  • Order
ORAL ORDER: IT IS HEREBY ORDERED that, as discussed at the scheduling conference, on or before May 11, 2021, the parties shall submit a final version of the scheduling order. ORDERED by Judge Jennifer L. Hall on 4/27/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 04/27/2021)
4/27/2021Minute Entry for proceedings held before Judge Jennifer L. Hall - Telephonic Scheduling Conference held on 4/27/2021. (*Court Reporter Jennifer Guy.) Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 04/27/2021)
4/23/202115
  • Order
ORAL ORDER Setting Telephonic Scheduling Conference: A Scheduling Conference is scheduled for April 27, 2021 at 04:00 PM Eastern Time before Judge Jennifer L. Hall. Counsel for Plaintiff shall send dial-in information directly to the Court by 4:00 PM on April 26, 2021 using the following e-mail address: Cailah_Garfinkel@ded.uscourts.gov. ORDERED by Judge Jennifer L. Hall on 4/23/2021. Associated Cases: 1:20-cv-01644-RGA-JLH, 1:20-cv-01646-RGA-JLH, 1:20-cv-01730-RGA-JLH, 1:20-cv-01734-RGA-JLH(ceg) (Entered: 04/23/2021)
4/13/2021
  • Answer
ANSWER to 10 Answer to Complaint, Counterclaim by Ravgen, Inc..(Farnan, Michael) (Entered: 04/13/2021)
4/7/2021Pro Hac Vice Attorneys Tung-On Kong, Kristina M. Hanson, Sarah A. Siedlak for Progenity, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) (Entered: 04/07/2021)
4/6/2021
  • Motion to Appear Pro Hac Vice
SO ORDERED, 12 Motion for Pro Hac Vice Appearance of Attorney Tung-On Kong, Kristina Hanson and Sarah A. Siedlak filed by Progenity, Inc. ORDERED by Judge Jennifer L. Hall on 4/6/2021. (ceg) (Entered: 04/06/2021)
4/5/2021 PROPOSED ORDER Proposed Scheduling Order by Ravgen, Inc.. (Attachments: # 1 Letter to The Honorable Jennifer L. Hall)(Farnan, Brian) (Entered: 04/05/2021)
4/5/2021
  • Motion to Appear Pro Hac Viceby Δ
MOTION for Pro Hac Vice Appearance of Attorney Tung-On Kong, Kristina Hanson and Sarah A. Siedlak - filed by Progenity, Inc.. (Attachments: # 1 Certification Tung-On Kong, # 2 Certification of Kristina Hanson, # 3 Certification of Sarah Siedlak)Motions referred to Jennifer L. Hall.(Liston, Ian) (Entered: 04/05/2021)
3/23/202111
  • Order
ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent" up through and including paragraph number 17 (i.e., up to and including case dispositive motions) and consistent with paragraphs 13-16 of Judge Andrew's "Rule 16 Scheduling Order - Patent"; and (ii) a letter, not to exceed three pages, setting forth (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Orders can be found on Judge Hall's and Judge Andrew's portions of the District Court's website. ORDERED by Judge Jennifer L. Hall on 3/23/2021. (ceg) (Entered: 03/23/2021)
3/23/2021
  • Answer
ANSWER to 1 Complaint with Jury Demand, COUNTERCLAIM against Ravgen, Inc. by Progenity, Inc..(Liston, Ian) Modified on 3/23/2021 (ceg). (Entered: 03/23/2021)
2/17/2021
  • Motion to Extend Time
SO ORDERED, 9 Stipulation to Extend Time to Answer, Move or Otherwise Respond to the Complaint to March 23, 2021 (*Reset Answer Deadline: Progenity, Inc. answer due 3/23/2021). ORDERED by Judge Jennifer L. Hall on 2/17/2021. (ceg) (Entered: 02/17/2021)
2/17/2021
  • Motion to Extend Timeby Δ
STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to the Complaint to March 23, 2021 - filed by Progenity, Inc.. (Liston, Ian) (Entered: 02/17/2021)
1/13/2021
  • Order
ORAL ORDER: The case is now referred to Magistrate Judge Jennifer L. Hall for all purposes through the case dispositive motion deadline. Ordered by Judge Richard G. Andrews on 1/13/2021. Associated Cases: 1:20-cv-01644-RGA, 1:20-cv-01646-RGA, 1:20-cv-01730-RGA, 1:20-cv-01734-RGA(nms) (Entered: 01/13/2021)
1/8/2021Pro Hac Vice Attorney Brian D. Matty,Deborah J. Mariottini for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) (Entered: 01/08/2021)
1/8/2021Pro Hac Vice Attorney Michael Ling for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) (Entered: 01/08/2021)
1/8/2021Pro Hac Vice Attorney John M. Desmarais,Jamie L. Kringstein,Kerri-Ann Limbeek for Ravgen, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) (Entered: 01/08/2021)
1/5/2021
  • Motion to Extend Time
SO ORDERED, re 8 STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Progenity, Inc. answer due 2/23/2021). Signed by Judge Richard G. Andrews on 1/5/2021. (nms) (Entered: 01/05/2021)
1/5/2021
  • Motion to Extend Timeby Δ
STIPULATION TO EXTEND TIME to Answer, Move or Otherwise Respond to Complaint to February 23, 2021 - filed by Progenity, Inc.. (Liston, Ian) (Entered: 01/05/2021)
1/5/2021
  • Order
SO ORDERED, re (7 in 20-cv-1734-RGA; 8 in 20-cv-1730-RGA) MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais, Kerri-Ann Limbeek, Jamie L. Kringstein, Brian D. Matty, Michael Ling, and Deborah J. Mariottini, filed by Ravgen, Inc.. Signed by Judge Richard G. Andrews on 1/5/2021. Associated Cases: 1:20-cv-01730-RGA, 1:20-cv-01734-RGA(nms) (Entered: 01/05/2021)
1/5/2021
  • Motion to Appear Pro Hac Vice
MOTION for Pro Hac Vice Appearance of Attorney John M. Desmarais, Kerri-Ann Limbeek, Jamie L. Kringstein, Brian D. Matty, Michael Ling, and Deborah J. Mariottini - filed by Ravgen, Inc.. (Farnan, Brian) (Entered: 01/05/2021)
12/29/2020 Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Ravgen, Inc.. (Farnan, Michael) (Entered: 12/29/2020)
12/23/2020Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:20-cv-01730-RGA, 1:20-cv-01734-RGA (rjb) (Entered: 12/23/2020)
12/22/2020 SUMMONS Returned Executed by Ravgen, Inc.. Progenity, Inc. served on 12/22/2020, answer due 1/12/2021. (Farnan, Michael) (Entered: 12/22/2020)
12/22/2020Summonses Issued (please complete the top portion of the form and print out for use/service). (mal) (Entered: 12/22/2020)
12/21/2020Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,727,720 B2 ;US 7,332,277 B2. (mal) (Entered: 12/22/2020)
12/21/2020Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) (Entered: 12/22/2020)
12/21/2020
  • Complaint
COMPLAINT FOR PATENT INFRINGEMENT - filed with Jury Demand against Progenity, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3411179.) - filed by Ravgen, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34, # 35 Exhibit 35, # 36 Exhibit 36, # 37 Exhibit 37, # 38 Exhibit 38, # 39 Civil Cover Sheet)(mal) (Entered: 12/22/2020)
One moment please. Additional information is being loaded. throbber